#BEGIN_DRUGCARD DB01992

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
85-61-0

# ChEBI_ID:
15346

# Chemical_Formula:
C21H36N7O16P3S

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Coenzyme A

# HET_ID:
COA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14+,15-,16-,20+/m0/s1

# InChI_Key:
InChIKey=RGJOEKWQDUBAIZ-VPHNIEJBSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00010

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1992

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
767.534

# Molecular_Weight_Mono:
767.115208365

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XVT

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.61

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
4.64e+00 g/l

# Primary_Accession_No:
DB01992

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936280

# PubChem_Substance_ID:
46507023

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00991

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)(CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:41 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Coenzyme_A

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
aac

# Phase_1_Metabolizing_Enzyme_1_ID:
4388

# Phase_1_Metabolizing_Enzyme_1_Name:
Aminoglycoside 2'-N-acetyltransferase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Aminoglycoside 2'-N-acetyltransferase
MHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
HAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSA
RARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDV
W

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P0A5N0

# Drug_Target_10_Cellular_Location:
Cytoplasm

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AB001488

# Drug_Target_10_GenBank_ID_Protein:
1881272

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
acpS

# Drug_Target_10_Gene_Sequence:
>366 bp
ATGATTTACGGCATTGGGCTGGACATTACCGAGCTTAAACGGATCGCCTCTATGGCTGGG
CGCCAGAAAAGGTTTGCCGAGCGGATTTTGACGCGAAGCGAGCTTGACCAATACTATGAG
CTTTCAGAGAAAAGAAAAAACGAATTTCTCGCGGGCAGATTCGCGGCAAAAGAAGCGTTC
TCGAAAGCATTTGGCACCGGCATTGGGAGGCAGCTCAGCTTTCAGGACATTGAAATTAGG
AAAGACCAAAATGGCAAGCCCTATATCATTTGTACGAAACTGAGCCAGGCCGCCGTTCAC
GTATCGATCACTCATACAAAAGAATACGCTGCCGCGCAGGTTGTGATTGAAAGGTTGTCA
AGCTAG

# Drug_Target_10_General_Function:
Lipid transport and metabolism

# Drug_Target_10_General_References:
11489886	Mootz HD, Finking R, Marahiel MA: 4'-phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis. J Biol Chem. 2001 Oct 5;276(40):37289-98. Epub 2001 Aug 6.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
3317

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
13718

# Drug_Target_10_Name:
Holo-[acyl-carrier-protein] synthase

# Drug_Target_10_Number_of_Residues:
121

# Drug_Target_10_PDB_ID:
1F7T

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF01648	ACPS

# Drug_Target_10_Protein_Sequence:
>Holo-[acyl-carrier-protein] synthase
MIYGIGLDITELKRIASMAGRQKRFAERILTRSELDQYYELSEKRKNEFLAGRFAAKEAF
SKAFGTGIGRQLSFQDIEIRKDQNGKPYIICTKLSQAAVHVSITHTKEYAAAQVVIERLS
S

# Drug_Target_10_Reaction:
CoA-[4'-phosphopantetheine] + apo-[acyl-carrier-protein] = adenosine 3',5'-bisphosphate + holo-[acyl-carrier-protein]

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Transfers the 4'-phosphopantetheine moiety from coenzyme A to a Ser of fatty acid acyl-carrier-protein ACP. Also modifies the D-alanyl carrier protein but fails to recognize PCP and acpK, an acyl carrier protein of secondary metabolism

# Drug_Target_10_SwissProt_ID:
P96618

# Drug_Target_10_SwissProt_Name:
ACPS_BACSU

# Drug_Target_10_Synonyms:
4'-phosphopantetheinyl transferase acpS
EC 2.7.8.7
Holo-ACP synthase

# Drug_Target_10_Theoretical_pI:
10.08

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
M36471

# Drug_Target_11_GenBank_ID_Protein:
143284

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
paiA

# Drug_Target_11_Gene_Sequence:
>519 bp
ATGAGTGTAAAAATGAAAAAATGCAGCCGGGAAGATTTACAAACACTTCAACAATTGAGT
ATTGAAACATTCAATGACATTTTTAAAGAACAGAACTCACCTGAAAATATGAAAGCCTAT
TTAGAAAGCGCATTTAACACTGAGCAGCTGGAAAAAGAGTTATCTAATATGTCTTCGCAA
TTCTTTTTTATTTACTTTGATCATGAAATCGCTGGATATGTAAAGGTCAATATCGATGAT
GCTCAGTCTGAAGAAATGGGTGCTGAATCACTTGAAATCGAGAGAATTTATATAAAGAAC
AGCTTTCAAAAACATGGGCTTGGCAAACATCTGCTGAATAAAGCGATAGAAATTGCGCTG
GAACGTAATAAAAAGAACATTTGGCTAGGTGTGTGGGAAAAAAATGAAAATGCCATTGCC
TTTTATAAGAAAATGGGGTTTGTTCAGACCGGCGCCCACTCATTTTATATGGGTGATGAA
GAACAAACGGATTTAATCATGGCTAAAACACTCATATAA

# Drug_Target_11_General_Function:
Transcription

# Drug_Target_11_General_References:
2108124	Honjo M, Nakayama A, Fukazawa K, Kawamura K, Ando K, Hori M, Furutani Y: A novel Bacillus subtilis gene involved in negative control of sporulation and degradative-enzyme production. J Bacteriol. 1990 Apr;172(4):1783-90.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
3125

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
20015

# Drug_Target_11_Name:
Protease synthase and sporulation negative regulatory protein PAI 1

# Drug_Target_11_Number_of_Residues:
172

# Drug_Target_11_PDB_ID:
1TIQ

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_11_Protein_Sequence:
>Protease synthase and sporulation negative regulatory protein PAI 1
MSVKMKKCSREDLQTLQQLSIETFNDTFKEQNSPENMKAYLESAFNTEQLEKELSNMSSQ
FFFIYFDHEIAGYVKVNIDDAQSEEMGAESLEIERIYIKNSFQKHGLGKHLLNKAIEIAL
ERNKKNIWLGVWEKNENAIAFYKKMGFVQTGAHSFYMGDEEQTDLIMAKTLI

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Possesses N1-acetyltransferase activity toward polyamine substrates including spermidine and spermine. capable of acetylating both spermidine and spermine. In this way it may function in regulating intracellular polyamine concentrations and/or binding capabilities. In addition to preventing toxicity due to polyamine excess, this function may also serve to regulate expression of certain bacterial gene products such as those involved in sporulation

# Drug_Target_11_SwissProt_ID:
P21340

# Drug_Target_11_SwissProt_Name:
PAIA_BACSU

# Drug_Target_11_Synonyms:
EC 2.3.1.-

# Drug_Target_11_Theoretical_pI:
4.95

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
U12338

# Drug_Target_12_GenBank_ID_Protein:
530805

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
aacC1

# Drug_Target_12_Gene_Sequence:
>534 bp
ATGTTACGCAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGGT
GGCTCAAGTATGGGCATCATTCGCACATGTAGGCTCGGCCCTGACCAAGTCAAATCCATG
CGGGCTGCTCTTGATCTTTTCGGTCGTGAGTTCGGAGACGTAGCCACCTACTCCCAACAT
CAGCCGGACTCCGATTACCTCGGGAACTTGCTCCGTAGTAAGACATTCATCGCGCTTGCT
GCCTTCGACCAAGAAGCGGTTGTTGGCGCTCTCGCGGCTTACGTTCTGCCCAGGTTTGAG
CAGCCGCGTAGTGAGATCTATATCTATGATCTCGCAGTCTCCGGCGAGCACCGGAGGCAG
GGCATTGCCACCGCGCTCATCAATCTCCTCAAGCATGAGGCCAACGCGCTTGGTGCTTAT
GTGATCTACGTGCAAGCAGATTACGGTGACGATCCCGCAGTGGCTCTCTATACAAAGTTG
GGCATACGGGAAGAAGTGATGCACTTTGATATCGACCCAAGTACCGCCACCTAA

# Drug_Target_12_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_12_General_References:
2549372	Wohlleben W, Arnold W, Bissonnette L, Pelletier A, Tanguay A, Roy PH, Gamboa GC, Barry GF, Aubert E, Davies J, et al.: On the evolution of Tn21-like multiresistance transposons: sequence analysis of the gene (aacC1) for gentamicin acetyltransferase-3-I(AAC(3)-I), another member of the Tn21-based expression cassette. Mol Gen Genet. 1989 Jun;217(2-3):202-8.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
3560

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
19442

# Drug_Target_12_Name:
Gentamicin 3'-acetyltransferase

# Drug_Target_12_Number_of_Residues:
177

# Drug_Target_12_PDB_ID:
1BO4

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_12_Protein_Sequence:
>Gentamicin 3'-acetyltransferase
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
QPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPRFEQPRSEIYIYDLAVSGEHRRQ
GIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT

# Drug_Target_12_Reaction:
acetyl-CoA + gentamicin C = CoA + N3'-acetylgentamicin C

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Responsible for gentamicin resistance and has a limited substrate range

# Drug_Target_12_SwissProt_ID:
P23181

# Drug_Target_12_SwissProt_Name:
AACC1_PSEAE

# Drug_Target_12_Synonyms:
AAC(3)-I
Aminoglycoside N(3')-acetyltransferase I
EC 2.3.1.60
Gentamicin acetyltransferase I

# Drug_Target_12_Theoretical_pI:
6.11

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Cytoplasm

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
J01636

# Drug_Target_13_GenBank_ID_Protein:
551814

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
lacA

# Drug_Target_13_Gene_Sequence:
>612 bp
TTGAACATGCCAATGACCGAAAGAATAAGAGCAGGCAAGCTATTTACCGATATGTGCGAA
GGCTTACCGGAAAAAAGACTTCGTGGGAAAACGTTAATGTATGAGTTTAATCACTCGCAT
CCATCAGAAGTTGAAAAAAGAGAAAGCCTGATTAAAGAAATGTTTGCCACGGTAGGGGAA
AACGCCTGGGTAGAACCGCCTGTCTATTTCTCTTACGGTTCCAACATCCATATAGGCCGC
AATTTTTATGCAAATTTCAATTTAACCATTGTCGATGACTACACGGTAACAATCGGTGAT
AACGTACTGATTGCACCCAACGTTACTCTTTCCGTTACGGGACACCCTGTACACCATGAA
TTGAGAAAAAACGGCGAGATGTACTCTTTTCCGATAACGATTGGCAATAACGTCTGGATC
GGAAGTCATGTGGTTATTAATCCAGGCGTCACCATCGGGGATAATTCTGTTATTGGCGCG
GGTAGTATCGTCACAAAAGACATTCCACCAAACGTCGTGGCGGCTGGCGTTCCTTGTCGG
GTTATTCGCGAAATAAACGACCGGGATAAGCACTATTATTTCAAAGATTATAAAGTTGAA
TCGTCAGTTTAA

# Drug_Target_13_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_13_General_References:
11937062	Wang XG, Olsen LR, Roderick SL: Structure of the lac operon galactoside acetyltransferase. Structure. 2002 Apr;10(4):581-8.
3901000	Hediger MA, Johnson DF, Nierlich DP, Zabin I: DNA sequence of the lactose operon: the lacA gene and the transcriptional termination region. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6414-8.
3922433	Fowler AV, Hediger MA, Musso RE, Zabin I: The amino acid sequence of thiogalactoside transacetylase of Escherichia coli. Biochimie. 1985 Jan;67(1):101-8.
6444453	Buchel DE, Gronenborn B, Muller-Hill B: Sequence of the lactose permease gene. Nature. 1980 Feb 7;283(5747):541-5.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
2560

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
22799

# Drug_Target_13_Name:
Galactoside O-acetyltransferase

# Drug_Target_13_Number_of_Residues:
203

# Drug_Target_13_PDB_ID:
1KRV

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_13_Protein_Sequence:
>Galactoside O-acetyltransferase
MNMPMTERIRAGKLFTDMCEGLPEKRLRGKTLMYEFNHSHPSEVEKRESLIKEMFATVGE
NAWVEPPVYFSYGSNIHIGRNFYANFNLTIVDDYTVTIGDNVLIAPNVTLSVTGHPVHHE
LRKNGEMYSFPITIGNNVWIGSHVVINPGVTIGDNSVIGAGSIVTKDIPPNVVAAGVPCR
VIREINDRDKHYYFKDYKVESSV

# Drug_Target_13_Reaction:
acetyl-CoA + a beta-D-galactoside = CoA + a 6-acetyl-beta-D-galactoside

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
May assist cellular detoxification by acetylating non- metabolizable pyranosides, thereby preventing their reentry into the cell

# Drug_Target_13_SwissProt_ID:
P07464

# Drug_Target_13_SwissProt_Name:
THGA_ECOLI

# Drug_Target_13_Synonyms:
EC 2.3.1.18
GAT
Thiogalactoside acetyltransferase

# Drug_Target_13_Theoretical_pI:
6.72

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum membrane
multi-pass membrane protein. Peroxisome
pero

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
HMGCR

# Drug_Target_14_GenBank_ID_Gene:
M11058

# Drug_Target_14_GenBank_ID_Protein:
306865

# Drug_Target_14_GeneCard_ID:
HMGCR

# Drug_Target_14_Gene_Name:
HMGCR

# Drug_Target_14_Gene_Sequence:
>2667 bp
ATGTTGTCAAGACTTTTTCGAATGCATGGCCTCTTTGTGGCCTCCCATCCCTGGGAAGTC
ATAGTGGGGACAGTGACACTGACCATCTGCATGATGTCCATGAACATGTTTACTGGTAAC
AATAAGATCTGTGGTTGGAATTATGAATGTCCAAAGTTTGAAGAGGATGTTTTGAGCAGT
GACATTATAATTCTGACAATAACACGATGCATAGCCATCCTGTATATTTACTTCCAGTTC
CAGAATTTACGTCAACTTGGATCAAAATATATTTTGGGTATTGCTGGCCTTTTCACAATT
TTCTCAAGTTTTGTATTCAGTACAGTTGTCATTCACTTCTTAGACAAAGAATTGACAGGC
TTGAATGAAGCTTTGCCCTTTTTCCTACTTTTGATTGACCTTTCCAGAGCAAGCACATTA
GCAAAGTTTGCCCTCAGTTCCAACTCACAGGATGAAGTAAGGGAAAATATTGCTCGTGGA
ATGGCAATTTTAGGTCCTACGTTTACCCTCGATGCTCTTGTTGAATGTCTTGTGATTGGA
GTTGGTACCATGTCAGGGGTACGTCAGCTTGAAATTATGTGCTGCTTTGGCTGCATGTCA
GTTCTTGCCAACTACTTCGTGTTCATGACTTTCTTCCCAGCTTGTGTGTCCTTGGTATTA
GAGCTTTCTCGGGAAAGCCGCGAGGGTCGTCCAATTTGGCAGCTCAGCCATTTTGCCCGA
GTTTTAGAAGAAGAAGAAAATAAGCCGAATCCTGTAACTCAGAGGGTCAAGATGATTATG
TCTCTAGGCTTGGTTCTTGTTCATGCTCACAGTCGCTGGATAGCTGATCCTTCTCCTCAA
AACAGTACAGCAGATACTTCTAAGGTTTCATTAGGACTGGATGAAAATGTGTCCAAGAGA
ATTGAACCAAGTGTTTCCCTCTGGCAGTTTTATCTCTCTAAAATGATCAGCATGGATATT
GAACAAGTTATTACCCTAAGTTTAGCTCTCCTTCTGGCTGTCAAGTACATCTTCTTTGAA
CAAACAGAGACAGAATCTACACTCTCATTAAAAAACCCTATCACATCTCCTGTAGTGACA
CAAAAGAAAGTCCCAGACAATTGTTGTAGACGTGAACCTATGCTGGTCAGAAATAACCAG
AAATGTGATTCAGTAGAGGAAGAGACAGGGATAAACCGAGAAAGAAAAGTTGAGGTTATA
AAACCCTTAGTGGCTGAAACAGATACCCCAAACAGAGCTACATTTGTGGTTGGTAACTCC
TCCTTACTCGATACTTCATCAGTACTGGTGACACAGGAACCTGAAATTGAACTTCCCAGG
GAACCTCGGCCTAATGAAGAATGTCTACAGATACTTGGGAATGCAGAGAAAGGTGCAAAA
TTCCTTAGTGATGCTGAGATCATCCAGTTAGTCAATGCTAAGCATATCCCAGCCTACAAG
TTGGAAACTCTGATGGAAACTCATGAGCGTGGTGTATCTATTCGCCGACAGTTACTTTCC
AAGAAGCTTTCAGAACCTTCTTCTCTCCAGTACCTACCTTACAGGGATTATAATTACTCC
TTGGTGATGGGAGCTTGTTGTGAGAATGTTATTGGATATATGCCCATCCCTGTTGGAGTG
GCAGGACCCCTTTGCTTAGATGAAAAAGAATTTCAGGTTCCAATGGCAACAACAGAAGGT
TGTCTTGTGGCCAGCACCAATAGAGGCTGCAGAGCAATAGGTCTTGGTGGAGGTGCCAGC
AGCCGAGTCCTTGCAGATGGGATGACTCGTGGCCCAGTTGTGCGTCTTCCACGTGCTTGT
GACTCTGCAGAAGTGAAAGCCTGGCTCGAAACATCTGAAGGGTTCGCAGTGATAAAGGAG
GCATTTGACAGCACTAGCAGATTTGCACGTCTACAGAAACTTCATACAAGTATAGCTGGA
CGCAACCTTTATATCCGTTTCCAGTCCAGGTCAGGGGATGCCATGGGGATGAACATGATT
TCAAAGGGTACAGAGAAAGCACTTTCAAAACTTCACGAGTATTTCCCTGAAATGCAGATT
CTAGCCGTTAGTGGTAACTATTGTACTGACAAGAAACCTGCTGCTATAAATTGGATAGAG
GGAAGAGGAAAATCTGTTGTTTGTGAAGCTGTCATTCCAGCCAAGGTTGTCAGAGAAGTA
TTAAAGACTACCACAGAGGCTATGATTGAGGTCAACATTAACAAGAATTTAGTGGGCTCT
GCCATGGCTGGGAGCATAGGAGGCTACAACGCCCATGCAGCAAACATTGTCACCGCCATC
TACATTGCCTGTGGACAGGATGCAGCACAGAATGTTGGTAGTTCAAACTGTATTACTTTA
ATGGAAGCAAGTGGTCCCACAAATGAAGATTTATATATCAGCTGCACCATGCCATCTATA
GAGATAGGAACGGTGGGTGGTGGGACCAACCTACTACCTCAGCAAGCCTGTTTGCAGATG
CTAGGTGTTCAAGGAGCATGCAAAGATAATCCTGGGGAAAATGCCCGGCAGCTTGCCCGA
ATTGTGTGTGGGACCGTAATGGCTGGGGAATTGTCACTTATGGCAGCATTGGCAGCAGGA
CATCTTGTCAAAAGTCACATGATTCACAACAGGTCGAAGATCAATTTACAAGACCTCCAA
GGAGCTTGCACCAAGAAGACAGCCTGA

# Drug_Target_14_General_Function:
Lipid transport and metabolism

# Drug_Target_14_General_References:
10391209	Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8.
10698924	Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J: Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000 Mar 1;19(5):819-30.
2991281	Luskey KL, Stevens B: Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J Biol Chem. 1985 Aug 25;260(18):10271-7.

# Drug_Target_14_HGNC_ID:
HGNC:5006

# Drug_Target_14_HPRD_ID:
00836

# Drug_Target_14_ID:
631

# Drug_Target_14_Locus:
5q13.3-q14

# Drug_Target_14_Molecular_Weight:
97477

# Drug_Target_14_Name:
3-hydroxy-3-methylglutaryl-coenzyme A reductase

# Drug_Target_14_Number_of_Residues:
888

# Drug_Target_14_PDB_ID:
1HWL

# Drug_Target_14_Pathway:
Alendronate pathway	SMP00095
Atorvastatin Pathway	SMP00131
Cerivastatin Pathway	SMP00111
Fluvastatin Pathway	SMP00119
Ibandronate Pathway	SMP00079
Lovastatin Pathway	SMP00099
Pamidronate Pathway	SMP00117
Pravastatin Pathway	SMP00089
Risedronate Pathway	SMP00112
Rosuvastatin Pathway	SMP00092
Zoledronate Pathway	SMP00107

# Drug_Target_14_Pfam_Domain_Function:
PF00368	HMG-CoA_red

# Drug_Target_14_Protein_Sequence:
>3-hydroxy-3-methylglutaryl-coenzyme A reductase
MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSS
DIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTG
LNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIG
VGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFAR
VLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKR
IEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVT
QKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNS
SLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYK
LETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGV
AGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRAC
DSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMI
SKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREV
LKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITL
MEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLAR
IVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA

# Drug_Target_14_Reaction:
(R)-mevalonate + CoA + 2 NADP+ = (S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H+

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
This transmembrane glycoprotein is involved in the control of cholesterol biosynthesis. It is the rate-limiting enzyme of sterol biosynthesis

# Drug_Target_14_SwissProt_ID:
P04035

# Drug_Target_14_SwissProt_Name:
HMDH_HUMAN

# Drug_Target_14_Synonyms:
EC 1.1.1.34
HMG-CoA reductase

# Drug_Target_14_Theoretical_pI:
6.72

# Drug_Target_14_Transmembrane_Regions:
10-39
57-78
90-114
124-149
160-187
192-220
315-339

# Drug_Target_15_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
AE005674

# Drug_Target_15_GenBank_ID_Protein:
24051474

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
fadR

# Drug_Target_15_Gene_Sequence:
>744 bp
TTGCTGTGTTATGGAAATCTCACTATGGTCATTAAGGCGCAAAGCCCGGCGGGTTTCGCG
GAAGAGTACATTATTGAAAGTATCTGGAATAACCGCTTCCCTCCCGGGACTATTTTGCCC
GCAGAACGTGAACTTTCAGAATTAATTGGCGTAACGCGTACTACGTTACGTGAAGTGTTA
CAGCGTCTGGCACGAGATGGCTGGTTGACCATTCAACATGGCAAGCCGACGAAGGTGAAT
AATTTCTGGGAAACTTCCGGTTTAAATATCCTTGAAACACTGGCGCGACTGGATCACGAA
AGTGTGCCGCAGCTTATTGATAATTTGCTGTCGGTGCGTACCAATATTTCCACTATTTTT
ATTCGCACCGCGTTTCGTCAGCATCCCGATAAAGCGCAGGAAGTGCTGGCTACCGCTAAT
GAAGTGGCCGATCACGCCGATGCCTTTGCCGAGCTGGATTACAACATATTCCGCGGCCTG
GCGTTTGCTTCCGGCAACCCGATTTACGGTCTGATCCTTAACGGGATGAAAGGGCTGTAT
ACGCGCATTGGTCGTCACTATTTCGCCAATCCGGAAGCGCGCAGTCTGGCGCTGGGCTTC
TACCACAAACTGTCGGCGTTGTGCAGTGAAGGCGCGCACGATCAGGTGTACGAAACAGTG
CGTCGCTATGGGCATGAGAGTGGCGAGATTTGGCACCGGATGCAGAAAAATCTGCCGGGT
GATTTAGCCATTCAGGGGCGATAA

# Drug_Target_15_General_Function:
Transcription

# Drug_Target_15_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
2528

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
26969

# Drug_Target_15_Name:
Fatty acid metabolism regulator protein

# Drug_Target_15_Number_of_Residues:
239

# Drug_Target_15_PDB_ID:
1HW2

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00392	GntR
PF07840	FadR_C

# Drug_Target_15_Protein_Sequence:
>Fatty acid metabolism regulator protein
MVIKAQSPAGFAEEYIIESIWNNRFPPGTILPAERELSELIGVTRTTLREVLQRLARDGW
LTIQHGKPTKVNNFWETSGLNILETLARLDHESVPQLIDNLLSVRTNISTIFIRTAFRQH
PDKAQEVLATANEVADHADAFAELDYNIFRGLAFASGNPIYGLILNGMKGLYTRIGRHYF
ANPEARSLALGFYHKLSALCSEGAHDQVYETVRRYGHESGEIWHRMQKNLPGDLAIQGR

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Multifunctional regulator of fatty acid metabolism

# Drug_Target_15_SwissProt_ID:
P0A8V9

# Drug_Target_15_SwissProt_Name:
FADR_SHIFL

# Drug_Target_15_Synonyms:
Not Available

# Drug_Target_15_Theoretical_pI:
7.03

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Not Available

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
Not Available

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
KAT5

# Drug_Target_16_Gene_Sequence:
Not Available

# Drug_Target_16_General_Function:
Not Available

# Drug_Target_16_General_References:
Not Available

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
7088

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
Not Available

# Drug_Target_16_Name:
Histone acetyltransferase KAT5

# Drug_Target_16_Number_of_Residues:
0

# Drug_Target_16_PDB_ID:
Not Available

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
Not Available

# Drug_Target_16_Protein_Sequence:
Not Available

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
Not Available

# Drug_Target_16_Specific_Function:
Not Available

# Drug_Target_16_SwissProt_ID:
Q92993

# Drug_Target_16_SwissProt_Name:
KAT5_HUMAN

# Drug_Target_16_Synonyms:
Not Available

# Drug_Target_16_Theoretical_pI:
Not Available

# Drug_Target_16_Transmembrane_Regions:
Not Available

# Drug_Target_17_Cellular_Location:
Cytoplasm

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
Not Available

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
dapD

# Drug_Target_17_Gene_Sequence:
Not Available

# Drug_Target_17_General_Function:
Amino acid transport and metabolism

# Drug_Target_17_General_References:
8880935	Binder DA, Blanchard JS, Roderick SL: Crystallization and preliminary crystallographic analysis of tetrahydrodipicolinate-N-succinyltransferase. Proteins. 1996 Sep;26(1):115-7.
9012664	Beaman TW, Binder DA, Blanchard JS, Roderick SL: Three-dimensional structure of tetrahydrodipicolinate N-succinyltransferase. Biochemistry. 1997 Jan 21;36(3):489-94.
9671504	Beaman TW, Blanchard JS, Roderick SL: The conformational change and active site structure of tetrahydrodipicolinate N-succinyltransferase. Biochemistry. 1998 Jul 21;37(29):10363-9.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
2376

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
29887

# Drug_Target_17_Name:
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase

# Drug_Target_17_Number_of_Residues:
274

# Drug_Target_17_PDB_ID:
1KGT

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_17_Protein_Sequence:
>2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MQQLQNVIESAFERRADITPANVDTVTREAVNQVIGLLDSGALRVAEKIDGQWVTHQWLK
KAVLLSFRINDNKVMDGAETRYYDKVPMKFADYDEARFQKEGFRVVPPATVRQGAFIARN
TVLMPSYVNIGAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQANPTIIED
NCFIGARSEVVEGVIVEEGSVISMGVYLGQSTRIYDRETGEIHYGRVPAGSVVVSGNLPS
KDGSYSLYCAVIVKKVDAKTRGKVGINELLRTID

# Drug_Target_17_Reaction:
succinyl-CoA + (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + H2O = CoA + N-succinyl-L-2-amino-6-oxoheptanedioate

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Succinyl-CoA + (S)-2,3,4,5-tetrahydropyridine- 2,6-dicarboxylate + H(2)O = CoA + N-succinyl-L-2-amino-6- oxoheptanedioate

# Drug_Target_17_SwissProt_ID:
P56220

# Drug_Target_17_SwissProt_Name:
DAPD_MYCBO

# Drug_Target_17_Synonyms:
EC 2.3.1.117
THP succinyltransferase
Tetrahydrodipicolinate N-succinyltransferase
Tetrahydropicolinate succinylase

# Drug_Target_17_Theoretical_pI:
5.43

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Cytoplasm

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
ACAT2

# Drug_Target_18_GenBank_ID_Gene:
S70154

# Drug_Target_18_GenBank_ID_Protein:
546901

# Drug_Target_18_GeneCard_ID:
ACAT2

# Drug_Target_18_Gene_Name:
ACAT2

# Drug_Target_18_Gene_Sequence:
>1194 bp
ATGAATGCAGGCTCAGATCCTGTGGTCATCGTCTCGGCGGCGCGGACCATCATAGGTTCC
TTCAATGGTGCCTTAGCTGCTGTTCCTGTCCAGGACCTGGGCTCCACTGTCATCAAAGAA
GTCTTGAAGAGGGCCACTGTGGCTCCGGAAGATGTGTCTGAGGTCATCTTTGGACATGTC
TTGGCAGCAGGCTGTGGGCAGAATCCTGTTAGACAAGCCAGTGTGGGTGCAGGAATTCCC
TACTCTGTTCCAGCATGGAGCTGCCAGATGATCTGTGGGTCAGGCCTAAAAGCTGTGTGC
CTTGCAGTCCAGTCAATAGGGATAGGAGACTCCAGCATTGTGGTTGCAGGAGGCATGGAA
AATATGAGCAAGGCTCCTCACTTGGCTTACTTGAGAACAGGAGTAAAGATAGGTGAGATG
CCACTGACTGACAGTATACTCTGTGATGGTCTTACAGATGCATTTCACAACTGTCATATG
GGTATTACAGCTGAAAATGTAGCCACAAAATGGCAAGTGAGTAGAGAAGATCAGGACAAG
GTTGCAGTTCTGTCCCAGAACAGGACAGAGAATGCACAGAAAGCTGGCCATTTTGACAAA
GAGATTGTACCAGTTTTGGTGTCAACTAGAAAAGGTCTTATTGAAGTTAAAACAGATGAG
TTTCCTCGCCATGGGAGCAACATAGAAGCCATGTCCAAGCTAAAGCCTTACTTTCTTACT
GATGGAACGGGAACAGTCACCCCAGCCAATGCTTCAGGAATAAATGATGGTGCTGCAGCT
GTTGCTCTTATGAAGAAGTCAGAAGCTGATAAACGTGGGCTTACACCTTTAGCACGGATA
GTTTCCTGGTCCCAAGTGGGTGTGGAGCCTTCCATTATGGGAATAGGACCAATTCCAGCC
ATAAAGCAAGCTGTTACAAAAGCAGGTTGGTCACTGGAAGATGTTGACATATTTGAAATC
AATGAAGCCTTTGCAGCTGTCTCTGCTGCAATAGTTAAAGAACTTGGATTAAACCCAGAG
AAGGTCAATATTGAAGGAGGGGCTATAGCCTTGGGCCACCCTCTTGGAGCATCTGGCTGT
CGAATTCTTGTGACCCTGTTACACACACTGGAGAGAATGGGCAGAAGTCGTGGTGTTGCA
GCCCTGTGCATTGGGGGTGGGATGGGAATAGCAATGTGTGTTCAGAGAGAATGA

# Drug_Target_18_General_Function:
Lipid transport and metabolism

# Drug_Target_18_General_References:
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
7911016	Song XQ, Fukao T, Yamaguchi S, Miyazawa S, Hashimoto T, Orii T: Molecular cloning and nucleotide sequence of complementary DNA for human hepatic cytosolic acetoacetyl-coenzyme A thiolase. Biochem Biophys Res Commun. 1994 May 30;201(1):478-85.

# Drug_Target_18_HGNC_ID:
HGNC:94

# Drug_Target_18_HPRD_ID:
00006

# Drug_Target_18_ID:
2409

# Drug_Target_18_Locus:
6q25.3-q26

# Drug_Target_18_Molecular_Weight:
41351

# Drug_Target_18_Name:
Acetyl-CoA acetyltransferase, cytosolic

# Drug_Target_18_Number_of_Residues:
397

# Drug_Target_18_PDB_ID:
1WL5

# Drug_Target_18_Pathway:
Alendronate pathway	SMP00095
Atorvastatin Pathway	SMP00131
Cerivastatin Pathway	SMP00111
Fluvastatin Pathway	SMP00119
Ibandronate Pathway	SMP00079
Lovastatin Pathway	SMP00099
Pamidronate Pathway	SMP00117
Pravastatin Pathway	SMP00089
Risedronate Pathway	SMP00112
Rosuvastatin Pathway	SMP00092
Zoledronate Pathway	SMP00107

# Drug_Target_18_Pfam_Domain_Function:
PF00108	Thiolase_N
PF02803	Thiolase_C

# Drug_Target_18_Protein_Sequence:
>Acetyl-CoA acetyltransferase, cytosolic
MNAGSDPVVIVSAARTIIGSFNGALAAVPVQDLGSTVIKEVLKRATVAPEDVSEVIFGHV
LAAGCGQNPVRQASVGAGIPYSVPAWSCQMICGSGLKAVCLAVQSIGIGDSSIVVAGGME
NMSKAPHLAYLRTGVKIGEMPLTDSILCDGLTDAFHNCHMGITAENVAKKWQVSREDQDK
VAVLSQNRTENAQKAGHFDKEIVPVLVSTRKGLIEVKTDEFPRHGSNIEAMSKLKPYFLT
DGTGTVTPANASGINDGAAAVVLMKKSEADKRGLTPLARIVSWSQVGVEPSIMGIGPIPA
IKQAVTKAGWSLEDVDIFEINEAFAAVSAAIVKELGLNPEKVNIEGGAIALGHPLGASGC
RILVTLLHTLERMGRSRGVAALCIGGGMGIAMCVQRE

# Drug_Target_18_Reaction:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_18_SwissProt_ID:
Q9BWD1

# Drug_Target_18_SwissProt_Name:
THIC_HUMAN

# Drug_Target_18_Synonyms:
Acetyl CoA transferase-like protein
Cytosolic acetoacetyl-CoA thiolase
EC 2.3.1.9

# Drug_Target_18_Theoretical_pI:
6.92

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Cytoplasm

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
J02631

# Drug_Target_19_GenBank_ID_Protein:
155618

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
phbA

# Drug_Target_19_Gene_Sequence:
>1176 bp
ATGAGCACCCCGTCCATCGTCATCGCCAGCGCCCGCACCGCGGTCGGTTCCTTCAACGGC
GCTTTCGCCAACACGCCCGCCCATGAACTCGGGGCGACCGTGATTTCGGCGGTTCTCGAG
CGCGCGGGCGTTGCGGCGGGCGAGGTGAACGAGGTGATTCTCGGCCAGGTGCTGCCGGCC
GGCGAAGGCCAGAACCCGGCCCGCCAGGCCGCCATGAAGGCCGGCGTGCCGCAGGAGGCG
ACCGCCTGGGGCATGAACCAGCTTTGCGGCTCGGGCCTGCGCGCCGTCGCGCTCGGCATG
CAGCAGATCGCCACGGGCGATGCGAGCATCATCGTCGCCGGCGGCATGGAATCCATGTCC
ATGGCCCCGCATTGCGCGCATCTGGCCGGCGTGAAGATGGGCGATTTCAAGATGATCGAC
ACGATGATCAAGGACGGCCTGACCGACGCCTTCTACGGCTACCACATGGGCACGACCGCC
GAGAATGTCGCCAAGCAGTGGCAGCTTTCCCGCGACGAGCAGGACGCCTTCGCCGTCGCC
TCGCAGAACAAGGCCGAGGCCGCCCAGAAGGACGGCCGCTTCAAGGACGAGATCGTTCCC
TTCATCGTCAAGGGCCGCAAGGGCGACATCACGGTCGATGCCGACGAATATATCCGCCAC
GGCGCGACGCTCGATTCCATGGCGAAGCTCCGCCCGGCCTTCGACAAGGAAGGCACGGTG
ACGGCCGGCAACGCCTCCGGCCTCAATGACGGCGCGGCCGCGGCCCTCCTGATGAGCGAA
GCGGAAGCCTCGCGCCGCGGCATCCAGCCGCTCGGCCGCATCGTTTCCTGGGCGACGGTC
GGCGTCGATCCCAAGGTCATGGGCACCGGCCCGATCCCGGCCTCCCGCAAGGCGCTCGAG
CGCGCCGGCTGGAAGATCGGCGATCTCGACCTCGTGGAAGCCAACGAAGCCTTCGCGGCG
CAGGCCTGCGCGGTCAACAAGGACCTCGGCTGGGATCCGTCCATCGTCAACGTCAACGGC
GGTGCCATCGCCATCGGCCACCCGATCGGCGCGTCCGGCGCCCGCATCCTCAACACGCTC
CTCTTCGAGATGAAGCGTCGCGGCGCCCGCAAGGGTCTCGCCACGCTCTGCATCGGCGGC
GGCATGGGCGTGGCGATGTGCATCGAGAGCCTTTAG

# Drug_Target_19_General_Function:
Lipid transport and metabolism

# Drug_Target_19_General_References:
10545327	Modis Y, Wierenga RK: A biosynthetic thiolase in complex with a reaction intermediate: the crystal structure provides new insights into the catalytic mechanism. Structure. 1999 Oct 15;7(10):1279-90.
10764581	Modis Y, Wierenga RK: Crystallographic analysis of the reaction pathway of Zoogloea ramigera biosynthetic thiolase. J Mol Biol. 2000 Apr 14;297(5):1171-82.
12501183	Kursula P, Ojala J, Lambeir AM, Wierenga RK: The catalytic cycle of biosynthetic thiolase: a conformational journey of an acetyl group through four binding modes and two oxyanion holes. Biochemistry. 2002 Dec 31;41(52):15543-56.
1673680	Palmer MA, Differding E, Gamboni R, Williams SF, Peoples OP, Walsh CT, Sinskey AJ, Masamune S: Biosynthetic thiolase from Zoogloea ramigera. Evidence for a mechanism involving Cys-378 as the active site base. J Biol Chem. 1991 May 5;266(13):8369-75.
2670935	Peoples OP, Sinskey AJ: Poly-beta-hydroxybutyrate biosynthesis in Alcaligenes eutrophus H16. Characterization of the genes encoding beta-ketothiolase and acetoacetyl-CoA reductase. J Biol Chem. 1989 Sep 15;264(26):15293-7.
2878929	Peoples OP, Masamune S, Walsh CT, Sinskey AJ: Biosynthetic thiolase from Zoogloea ramigera. III. Isolation and characterization of the structural gene. J Biol Chem. 1987 Jan 5;262(1):97-102.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
2596

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
40474

# Drug_Target_19_Name:
Acetyl-CoA acetyltransferase

# Drug_Target_19_Number_of_Residues:
392

# Drug_Target_19_PDB_ID:
1M1T

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00108	Thiolase_N
PF02803	Thiolase_C

# Drug_Target_19_Protein_Sequence:
>Acetyl-CoA acetyltransferase
MSTPSIVIASARTAVGSFNGAFANTPAHELGATVISAVLERAGVAAGEVNEVILGQVLPA
GEGQNPARQAAMKAGVPQEATAWGMNQLCGSGLRAVALGMQQIATGDASIIVAGGMESMS
MAPHCAHLAGGVKMGDFKMIDTMIKDGLTDAFYGYHMGTTAENVAKQWQLSRDEQDAFAV
ASQNKAEAAQKDGRFKDEIVPFIVKGRKGDITVDADEYIRHGATLDSMAKLRPAFDKEGT
VTAGNASGLNDGAAAALLMSEAEASRRGIQPLGRIVSWATVGVDPKVMGTGPIPASRKAL
ERAGWKIGDLDLVEANEAFAAQACAVNKDLGWDPSIVNVNGGAIAIGHPIGASGARILNT
LLFEMKRRGARKGLATLCIGGGMGVAMCIESL

# Drug_Target_19_Reaction:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
2 acetyl-CoA = CoA + acetoacetyl-CoA

# Drug_Target_19_SwissProt_ID:
P07097

# Drug_Target_19_SwissProt_Name:
THIL_ZOORA

# Drug_Target_19_Synonyms:
Acetoacetyl-CoA thiolase
EC 2.3.1.9

# Drug_Target_19_Theoretical_pI:
6.26

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE008900

# Drug_Target_1_GenBank_ID_Protein:
16422835

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
acs

# Drug_Target_1_Gene_Sequence:
>1959 bp
TTATGACGGCATCGCGATGGCCTGCTTCTCTTCGAGCAGTTTCTCCACCACGCCAGGATC
GGCGAGAGTCGAGGTATCGCCCAGATTGCTGGTATCGCCCGCCGCGATTTTGCGCAAAAT
GCGGCGCATAATTTTGCCGGAACGGGTTTTTGGCAGTGAGTCGGTCCAGTGCAGCACGTC
CGGCGTCGCCAGTGGGCCAATCTCTTTACGTACCCAGTTGCGCACCTCCGCGTACAGTTC
TGGCGACGGCTCCTCGCCGTGGTTGAGCGTCACATAAGCGTAAATCGCCTGGCCTTTGAT
AGCGTGTGGAATACCCACCACCGCCGCTTCGGCGATCTTCGGATGCGCCACCAGCGCTGA
CTCGATTTCCGCCGTACCCAGACGGTGGCCGGAGACGTTTAACACGTCGTCCACGCGACC
GGTGATCCAGTAATAGCCGTCCTCATCGCGACGCGCGCCGTCGCCGCTGAAATACATATT
CTTAAAGGTAGAGAAATAGGTCTGCTCAAAACGTTCATGATCGCCGAACAGAGTGCGCGC
CTGGCCCGGCCAGGAATCGGTGATGACCAGATTGCCTTCCGTCGCGCCTTCTTGCGGATG
GCCTTCGTTATCCACCAGCGCAGGCTGTACGCCAAAGAAAGGACGGGTGGCGGAACCGGC
TTTCAGTTCGATAGCGCCTGGTAGCGGCGTGATCATAAAACCGCCTGTTTCAGTCTGCCA
CCAGGTGTCGACGACCGGACATTTTTCCTTGCCGATCTTCTTCCAGTACCATTCCCACGC
TTCGGGATTGATCGGCTCGCCGACGGAACCCAGAATGCGCAGTGAAGAACGGTCGGTGCC
TTCAATGGCTTTATCGCCTTCCGCCATCAGCGCGCGGATGGCCGTCGGGGCGGTATAGAG
AATGTTGACCTGGTGTTTGTCGACCACCTGGCACATGCGAGCGGGCGTTGGCCAATTCGG
CACGCCTTCAAACATTAAGGTGGTCGCGCCGCAGGCCAGCGGGCCATACAACAGATAGCT
GTGCCCCGTCACCCAACCCACATCGGCGGTACACCAGTAAATATCGCCAGGGTGATAATC
AAAGACATACTTAAAGGTGGTCGCGGCGTAGACCAGATAGCCGCCGGTGGTGTGCAGCAC
GCCTTTCGGCTTGCCGGTGGAGCCGGAGGTATAAAGGATAAACAGCGGATCTTCGGCATT
CATCGCTTCAGGCTGGTGCTCAGGGCTGGCTTTTTCAATCAAATCGCGCCACCACAGGTC
GCGGCCTTCTTGCCAGTCAATGTCGCTGCCGGTGCGCTTCAGGACGATCACATGCTCAAC
GCTAGTGACATTCGGGTTTTTCAGCGCGTCATCGACATTCTTTTTCAGCGGGATACTGCG
TCCGGCACGTACACCTTCGTCAGCGGTGATCACCAGCCGCGAGCTGGAGTCGATAATGCG
TCCGGCGACGGCTTCCGGCGAGAAGCCCCCGAAGATCACCGAATGCACCGCACCGATGCG
GGCGCAGGCCAACATTGCCACCGCCGCTTCCGGCACCATCGGCATATAAATCGCTACCAC
ATCGCCTTTTTTAATGCCCAGATCCAGCAGCGTATTCGCGAAACGGCAGACATCGCGATG
CAGTTCGCGATAAGAGATATGTTTACTCTGCGACGTGTCATCGCCTTCCCAGATAATGGC
GGTGCGATCGCCATTTTCCTGCAAATGGCGGTCAAGACAGTTCGCCGCCAGATTCAGCGT
GCCGTCCTCGTACCATTTAATCGACACATTGCCTGGCGCAAAGGAGGTGTTTTTCACTTT
TTGGTACGGCGTGATCCAATCGAGAATTTTTCCCTGTTCGCCCCAAAACGTATCGGGGTC
GTTAATAGACTGTTTATATTTAGTCTCATACTGCTCTGGATTTATCAGGCAACGATCCGC
AATGTTGGCGGGAATGGCGTGTTTATGTGTTTGGCTCAT

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
12493915	Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC: Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science. 2002 Dec 20;298(5602):2390-2.
12627952	Gulick AM, Starai VJ, Horswill AR, Homick KM, Escalante-Semerena JC: The 1.75 A crystal structure of acetyl-CoA synthetase bound to adenosine-5'-propylphosphate and coenzyme A. Biochemistry. 2003 Mar 18;42(10):2866-73.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3489

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
72153

# Drug_Target_1_Name:
Acetyl-coenzyme A synthetase

# Drug_Target_1_Number_of_Residues:
652

# Drug_Target_1_PDB_ID:
1PG4

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00501	AMP-binding

# Drug_Target_1_Protein_Sequence:
>Acetyl-coenzyme A synthetase
MSQTHKHAIPANIADRCLINPEQYETKYKQSINDPDTFWGEQGKILDWITPYQKVKNTSF
APGNVSIKWYEDGTLNLAANCLDRHLQENGDRTAIIWEGDDTSQSKHISYRELHRDVCRF
ANTLLDLGIKKGDVVAIYMPMVPEAAVAMLACARIGAVHSVIFGGFSPEAVAGRIIDSSS
RLVITADEGVRAGRSIPLKKNVDDALKNPNVTSVEHVIVLKRTGSDIDWQEGRDLWWRDL
IEKASPEHQPEAMNAEDPLFILYTSGSTGKPKGVLHTTGGYLVYAATTFKYVFDYHPGDI
YWCTADVGWVTGHSYLLYGPLACGATTLMFEGVPNWPTPARMCQVVDKHQVNILYTAPTA
IRALMAEGDKAIEGTDRSSLRILGSVGEPINPEAWEWYWKKIGKEKCPVVDTWWQTETGG
FMITPLPGAIELKAGSATRPFFGVQPALVDNEGHPQEGATEGNLVITDSWPGQARTLFGD
HERFEQTYFSTFKNMYFSGDGARRDEDGYYWITGRVDDVLNVSGHRLGTAEIESALVAHP
KIAEAAVVGIPHAIKGQAIYAYVTLNHGEEPSPELYAEVRNWVRKEIGPLATPDVLHWTD
SLPKTRSGKIMRRILRKIAAGDTSNLGDTSTLADPGVVEKLLEEKQAIAMPS

# Drug_Target_1_Reaction:
ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Enables the cell to use acetate during aerobic growth to generate energy via the TCA cycle, and biosynthetic compounds via the glyoxylate shunt. Acetylates cheY, the response regulator involved in flagellar movement and chemotaxis

# Drug_Target_1_SwissProt_ID:
Q8ZKF6

# Drug_Target_1_SwissProt_Name:
ACSA_SALTY

# Drug_Target_1_Synonyms:
Acetate--CoA ligase
Acyl- activating enzyme
EC 6.2.1.1

# Drug_Target_1_Theoretical_pI:
5.71

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Not Available

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
L12033

# Drug_Target_20_GenBank_ID_Protein:
433715

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
vatD

# Drug_Target_20_Gene_Sequence:
>630 bp
ATGGGTCCGAATCCTATGAAAATGTATCCTATAGAAGGAAACAAATCAGTACAATTTATC
AAACCTATTTTAGAAAAATTAGAAAATGTTGAGGTTGGAGAATACTCATATTATGATTCT
AAGAATGGAGAAACTTTTGATAAGCAAATTTTATATCATTATCCAATCTTAAACGATAAG
TTAAAAATAGGTAAATTTTGCTCAATAGGACCAGGTGTAACTATTATTATGAATGGAGCA
AATCATAGAATGGATGGCTCAACATATCCATTTAATTTATTTGGTAATGGATGGGAGAAA
CATATGCCAAAATTAGATCAACTACCTATTAAGGGGGATACAATAATAGGTAATGATGTA
TGGATAGGAAAAGATGTTGTAATTATGCCAGGAGTAAAAATCGGGGATGGTGCAATAGTA
GCTGCTAATTCTGTTGTTGTAAAAGATATAGCGCCATACATGTTAGCTGGAGGAAATCCT
GCTAACGAAATAAAACAAAGATTTGATCAAGATACAATAAATCAGCTGCTTGATATAAAA
TGGTGGAATTGGCCAATAGACATTATTAATGAGAATATAGATAAAATTCTTGATAATAGC
ATCATTAGAGAAGTCATATGGAAAAAATGA

# Drug_Target_20_General_Function:
Involved in acyltransferase activity

# Drug_Target_20_General_References:
8257133	Rende-Fournier R, Leclercq R, Galimand M, Duval J, Courvalin P: Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob Agents Chemother. 1993 Oct;37(10):2119-25.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
2285

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
23650

# Drug_Target_20_Name:
Streptogramin A acetyltransferase

# Drug_Target_20_Number_of_Residues:
209

# Drug_Target_20_PDB_ID:
1MR7

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_20_Protein_Sequence:
>Streptogramin A acetyltransferase
MGPNPMKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDK
LKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDV
WIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIK
WWNWPIDIINENIDKILDNSIIREVIWKK

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Inactivates the A compounds of streptogramin antibiotics by acetylation, thus providing resistance to these antibiotics

# Drug_Target_20_SwissProt_ID:
P50870

# Drug_Target_20_SwissProt_Name:
VATD_ENTFC

# Drug_Target_20_Synonyms:
EC 2.3.1.-
Vat(D)
Virginiamycin acetyltransferase D

# Drug_Target_20_Theoretical_pI:
5.75

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
Not Available

# Drug_Target_21_GenBank_ID_Protein:
Not Available

# Drug_Target_21_GeneCard_ID:
Not Available

# Drug_Target_21_Gene_Name:
CS

# Drug_Target_21_Gene_Sequence:
Not Available

# Drug_Target_21_General_Function:
Not Available

# Drug_Target_21_General_References:
Not Available

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
6969

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
Not Available

# Drug_Target_21_Name:
Citrate synthase, mitochondrial

# Drug_Target_21_Number_of_Residues:
0

# Drug_Target_21_PDB_ID:
Not Available

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
Not Available

# Drug_Target_21_Protein_Sequence:
Not Available

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
Not Available

# Drug_Target_21_Specific_Function:
Not Available

# Drug_Target_21_SwissProt_ID:
O75390

# Drug_Target_21_SwissProt_Name:
CISY_HUMAN

# Drug_Target_21_Synonyms:
Not Available

# Drug_Target_21_Theoretical_pI:
Not Available

# Drug_Target_21_Transmembrane_Regions:
Not Available

# Drug_Target_22_Cellular_Location:
Cytoplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
M77744

# Drug_Target_22_GenBank_ID_Protein:
145898

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
fabH

# Drug_Target_22_Gene_Sequence:
>954 bp
ATGTATACGAAGATTATTGGTACTGGCAGCTATCTGCCCGAACAAGTGCGGACAAACGCC
GATTTGGAAAAAATGGTGGACACCTCTGACGAGTGGATTGTCACTCGTACCGGTATCCGC
GAACGCCACATTGCCGCGCCAAACGAAACCGTTTCAACCATGGGCTTTGAAGCGGCGACA
CGCGCAATTGAGATGGCGGGCATTGAGAAAGACCAGATTGGCCTGATCGTTGTGGCAACG
ACTTCTGCTACGCACGCTTTCCCGAGCGCAGCTTGTCAGATTCAAAGCATGTTGGGCATT
AAAGGTTGCCCGGCATTTGACGTTGCAGCAGCCTGCGCAGGTTTCACCTATGCATTAAGC
GTAGCCGATCAATACGTGAAATCTGGGGCGGTGAAGTATGCTCTGGTCGTCGGTTCCGAT
GTACTGGCGCGCACCTGCGATCCAACCGATCGTGGGACTATTATTATTTTTGGCGATGGC
GCGGGCGCTGCGGTGCTGGCTGCCTCTGAAGAGCCGGGAATCATTTCCACCCATCTGCAT
GCCGACGGTAGTTATGGTGAATTGCTGACGCTGCCAAACGCCGACCGCGTGAATCCAGAG
AATTCAATTCATCTGACGATGGCGGGCAACGAAGTCTTCAAGGTTGCGGTAACGGAACTG
GCGCACATCGTTGATGAGACGCTGGCGGCGAATAATCTTGACCGTTCTCAACTGGACTGG
CTGGTTCCGCATCAGGCTAACCTGCGTATTATCAGTGCAACGGCGAAAAAACTCGGTATG
TCTATGGATAATGTCGTGGTGACGCTGGATCGCCACGGTAATACCTCTGCGGCCTCTGTC
CCGTGCGCGCTGGATGAAGCTGTACGCGACGGGCGCATTAAGCCGGGGCAGTTGGTTCTG
CTTGAAGCCTTTGGCGGTGGATTCACCTGGGGCTCCGCGCTGGTTCGTTTCTAG

# Drug_Target_22_General_Function:
Lipid transport and metabolism

# Drug_Target_22_General_References:
10593943	Qiu X, Janson CA, Konstantinidis AK, Nwagwu S, Silverman C, Smith WW, Khandekar S, Lonsdale J, Abdel-Meguid SS: Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. J Biol Chem. 1999 Dec 17;274(51):36465-71.
10673437	Davies C, Heath RJ, White SW, Rock CO: The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli. Structure. 2000 Feb 15;8(2):185-95.
11078736	Zhang YM, Rao MS, Heath RJ, Price AC, Olson AJ, Rock CO, White SW: Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III. J Biol Chem. 2001 Mar 16;276(11):8231-8. Epub 2000 Nov 14.
11243824	Qiu X, Janson CA, Smith WW, Head M, Lonsdale J, Konstantinidis AK: Refined structures of beta-ketoacyl-acyl carrier protein synthase III. J Mol Biol. 2001 Mar 16;307(1):341-56.
11375394	Khandekar SS, Gentry DR, Van Aller GS, Warren P, Xiang H, Silverman C, Doyle ML, Chambers PA, Konstantinidis AK, Brandt M, Daines RA, Lonsdale JT: Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH). J Biol Chem. 2001 Aug 10;276(32):30024-30. Epub 2001 May 24.
1314802	Verwoert II, Verbree EC, van der Linden KH, Nijkamp HJ, Stuitje AR: Cloning, nucleotide sequence, and expression of the Escherichia coli fabD gene, encoding malonyl coenzyme A-acyl carrier protein transacylase. J Bacteriol. 1992 May;174(9):2851-7.
1339356	Magnuson K, Oh W, Larson TJ, Cronan JE Jr: Cloning and nucleotide sequence of the fabD gene encoding malonyl coenzyme A-acyl carrier protein transacylase of Escherichia coli. FEBS Lett. 1992 Mar 16;299(3):262-6.
1447160	Oh W, Larson TJ: Physical locations of genes in the rne (ams)-rpmF-plsX-fab region of the Escherichia coli K-12 chromosome. J Bacteriol. 1992 Dec;174(23):7873-4.
1551888	Tsay JT, Oh W, Larson TJ, Jackowski S, Rock CO: Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. J Biol Chem. 1992 Apr 5;267(10):6807-14.
8631920	Heath RJ, Rock CO: Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J Biol Chem. 1996 May 3;271(18):10996-1000.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
615

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
33515

# Drug_Target_22_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 3

# Drug_Target_22_Number_of_Residues:
317

# Drug_Target_22_PDB_ID:
1HNK

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF08541	ACP_syn_III_C
PF08545	ACP_syn_III

# Drug_Target_22_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 3
MYTKIIGTGSYLPEQVRTNADLEKMVDTSDEWIVTRTGIRERHIAAPNETVSTMGFEAAT
RAIEMAGIEKDQIGLIVVATTSATHAFPSAACQIQSMLGIKGCPAFDVAAACAGFTYALS
VADQYVKSGAVKYALVVGSDVLARTCDPTDRGTIIIFGDGAGAAVLAASEEPGIISTHLH
ADGSYGELLTLPNADRVNPENSIHLTMAGNEVFKVAVTELAHIVDETLAANNLDRSQLDW
LVPHQANLRIISATAKKLGMSMDNVVVTLDRHGNTSAASVPCALDEAVRDGRIKPGQLVL
LEAFGGGFTWGSALVRF

# Drug_Target_22_Reaction:
an acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = a 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for acetyl-CoA. Its substrate specificity determines the biosynthesis of straight-chain of fatty acids instead of branched-chain

# Drug_Target_22_SwissProt_ID:
P0A6R0

# Drug_Target_22_SwissProt_Name:
FABH_ECOLI

# Drug_Target_22_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase III
Beta-ketoacyl-ACP synthase III
EC 2.3.1.41
EcFabH
KAS III

# Drug_Target_22_Theoretical_pI:
4.89

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Cytoplasm

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
Not Available

# Drug_Target_23_GenBank_ID_Gene:
U82167

# Drug_Target_23_GenBank_ID_Protein:
2102704

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
frc

# Drug_Target_23_Gene_Sequence:
>1287 bp
ATGACTAAACCATTAGATGGAATTAATGTGCTTGACTTTACCCACGTCCAGGCAGGTCCT
GCCTGTACACAGATGATGGGTTTCTTGGGCGCAAACGTCATCAAGATTGAAAGACGTGGT
TCCGGAGATATGACTCGTGGATGGCTGCAGGACAAACCAAATGTTGATTCCCTGTATTTC
ACGATGTTCAACTGTAACAAACGTTCGATTGAACTGGACATGAAAACCCCGGAAGGCAAA
GAGCTTCTGGAACAGATGATCAAGAAAGCCGACGTCATGGTCGAAAACTTCGGACCAGGC
GCACTGGACCGTATGGGCTTTACTTGGGAATACATTCAGGAACTGAATCCACGCGTCATT
CTGGCTTCCGTTAAAGGCTATGCAGAAGGCCACGCCAACGAACACCTGAAAGTTTATGAA
AACGTTGCACAGTGTTCCGGCGGTGCTGCAGCTACCACCGGTTTCTGGGATGGTCCTCCA
ACCGTTTCCGGCGCTGCTCTGGGTGACTCCAACTCCGGTATGCACCTGATGATCGGTATT
CTGGCCGCTCTGGAAATGCGTCACAAAACCGGCCGTGGTCAGAAAGTTGCCGTCGCTATG
CAGGACGCTGTTCTGAATCTGGTTCGTATCAAACTGCGTGACCAGCAACGTCTGGAAAGA
ACCGGCATTCTGGCTGAATACCCACAGGCTCAGCCTAACTTTGCCTTCGACAGAGACGGT
AACCCACTGTCCTTCGACAACATCACTTCCGTTCCACGTGGTGGTAACGCAGGTGGCGGC
GGCCAGCCAGGCTGGATGCTGAAATGTAAAGGTTGGGAAACCGATGCGGACTCCTACGTT
TACTTCACCATCGCTGCAAACATGTGGCCACAGATCTGCGACATGATCGACAAGCCAGAA
TGGAAAGACGACCCAGCCTACAACACATTCGAAGGTCGTGTTGACAAGCTGATGGACATC
TTCTCCTTCATCGAAACCAAGTTCGCTGACAAGGACAAATTCGAAGTTACCGAATGGGCT
GCCCAGTACGGCATTCCTTGCGGTCCGGTCATGTCCATGAAAGAACTGGCTCACGATCCT
TCCCTGCAGAAAGTTGGTACCGTCGTTGAAGTTGTCGACGAAATTCGTGGTAACCACCTG
ACCGTTGGCGCACCGTTCAAATTCTCCGGATTCCAGCCGGAAATTACCCGTGCTCCGCTG
TTGGGCGAACATACCGACGAAGTTCTGAAAGAACTGGGTCTTGACGATGCCAAGATCAAG
GAACTGCATGCAAAACAGGTAGTTTGA

# Drug_Target_23_General_Function:
Energy production and conversion

# Drug_Target_23_General_References:
2361939	Baetz AL, Allison MJ: Purification and characterization of formyl-coenzyme A transferase from Oxalobacter formigenes. J Bacteriol. 1990 Jul;172(7):3537-40.
9150242	Sidhu H, Ogden SD, Lung HY, Luttge BG, Baetz AL, Peck AB: DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes. J Bacteriol. 1997 May;179(10):3378-81.

# Drug_Target_23_HGNC_ID:
Not Available

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
2396

# Drug_Target_23_Locus:
Not Available

# Drug_Target_23_Molecular_Weight:
47328

# Drug_Target_23_Name:
Formyl-coenzyme A transferase

# Drug_Target_23_Number_of_Residues:
428

# Drug_Target_23_PDB_ID:
1P5R

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF02515	CoA_transf_3

# Drug_Target_23_Protein_Sequence:
>Formyl-coenzyme A transferase
MTKPLDGINVLDFTHVQAGPACTQMMGFLGANVIKIERRGSGDMTRGWLQDKPNVDSLYF
TMFNCNKRSIELDMKTPEGKELLEQMIKKADVMVENFGPGALDRMGFTWEYIQELNPRVI
LASVKGYAEGHANEHLKVYENVAQCSGGAAATTGFWDGPPTVSGAALGDSNSGMHLMIGI
LAALEMRHKTGRGQKVAVAMQDAVLNLVRIKLRDQQRLERTGILAEYPQAQPNFAFDRDG
NPLSFDNITSVPRGGNAGGGGQPGWMLKCKGWETDADSYVYFTIAANMWPQICDMIDKPE
WKDDPAYNTFEGRVDKLMDIFSFIETKFADKDKFEVTEWAAQYGIPCGPVMSMKELAHDP
SLQKVGTVVEVVDEIRGNHLTVGAPFKFSGFQPEITRAPLLGEHTDEVLKELGLDDAKIK
ELHAKQVV

# Drug_Target_23_Reaction:
formyl-CoA + oxalate = formate + oxalyl-CoA

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Catalyzes the transfer of the CoA moiety from formyl-CoA to oxalate. Essential enzyme for the bacterium survival, as it relies on oxalic acid as its sole source of energy

# Drug_Target_23_SwissProt_ID:
O06644

# Drug_Target_23_SwissProt_Name:
FCTA_OXAFO

# Drug_Target_23_Synonyms:
EC 2.8.3.16
Formyl-CoA transferase

# Drug_Target_23_Theoretical_pI:
5.10

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Not Available

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
X12455

# Drug_Target_24_GenBank_ID_Protein:
580740

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
Not Available

# Drug_Target_24_Gene_Sequence:
>1917 bp
GTGAGCGAAATCATCCGCGTACCCGATATCGGCGGCGATGGGGAAGTCATCGAATTGCTG
GTCAAGACCGGCGACCTCATCGAGGTCGAGCAGGGGCTGGTGGTGCTGGAGTCCGCCAAG
GCGAGCATGGAAGTTCCCAGTCCCAAGGCCGGAGTGGTCAAGAGCGTGAGCGTCAAGCTG
GGCGACAAGCTCAAGGAAGGCGACGCGATCATCGAGCTGGAACCTGCCGCCGGTGCCGCG
GCGGCACCTGCCGAAGCGGCGGCCGTGCCCGCCGCGCCGACCCAGGCCGTCGACGAGGCC
GAGGCGCCCTCTCCCGGCGCCTCCGCCACGCCCGCGCCGGCCGCCGCCAGCCAGGAGGTC
CGGGTTCCCGACATCGGCTCGGCCGGCAAGGCACGGGTCATCGAGGTGCTGGTCAAGGCC
GGCGACCAGGTCCAGGCCGAGCAGTCGCTGATCGTGCTGGAGTCCGACAAGGCCAGCATG
GAGATCCCCTCCCCGGCTTCCGGAGTGGTGGAAAGCGTCGCCATCCAGTTGAACGCCGAG
GTCGGCACCGGCGACCTGATCCTCACCCTGCGCACCACCGGCGCCCAGGCCCAGCCTACG
GCGCCCGCCGCGGCCGCGGCCGCGAGCCCGGCACCCGCTCCGCTGGCTCCGGCCGCCGCC
GGTCCCCAGGAAGTCAAGGTCCCGGACATCGGCTCGGCCGGCAAGGCACGGGTCATCGAG
GTGCTGGTCAAGGCCGGCGACCAGGTCCAGGCCGAACAGTCGCTGATCGTGCTGGAATCC
GACAAGGCCAGCATGGAGATCCCCTCCCCGGCCGCCGGGGTGGTGGAAAGCGTCGCCGTC
CAGTTGAACGCCGAGGTCGGCACCGGCGATCAGATCCTCACCCTGCGCGTCGCCGGCGCC
GCGCCGAGCGGCCCCCGCGCCCGCGGCAGCCCCGGCCAAGCCGCCGCCGCTGCGGCCGCT
GCCCCGGCTCCGGCCCCGGTCGGCGCACCGAGCCGCAACGGCGCCAAGGTGCATGCCGGC
CCCGCCGTGCGCCAACTGGCCCGCGAGTTCGGCGTCGAACTGGCGGCGATCAACAGCACC
GGTCCGCGCGGGCGCATCCTCAAGGAGGACGTGCAGGCCTACGTCAAGGCGATGATGCAG
AAGGCCAAGGAGGCGCCGGCCGCCGGCGCGGCCAGCGGCGCCGGCATCCCGCCGATTCCG
CCGGTCGACTTCGCCAAGTACGGCGAAATCGAAGAAGTGCCGATGACTCGCCTGATGCAG
ATCGGCGCGACCAACCTGCACCGCAGTTGGCTGAACGTGCCGCACGTGACCCAGTTCGAG
TCGGCCGATATCACCGAGCTGGAAGCCTTCCGCGTCGCGCAGAAGGCCGTCGCCGAGAAG
GCCGGGGTCAAGCTGACCGTGCTGCCGCTGCTGCTCAAGGCCTGCGCCTACCTGCTCAAG
GAGCTGCCGGACTTCAACAGCTCCCTGGCACCCAGCGGCCAGGCGCTGATCCGCAAGAAG
TACGTGCACATCGGCTTCGCCGTGGACACCCCGGACGGCCTGCTGGTGCCGGTAATCCGC
AACGTCGACCAGAAGAGCCTGCTGCAACTGGCCGCCGAGGCCGCCGAACTGGCGGAGAAG
GCGCGCAGCAAGAAGCTCGGCGCCGACGCCATGCAGGGTGCCTGCTTCACCATCTCCAGC
CTCGGCCACATCGGCGGCACGGCCTTCACGCCGATCGTCAACGCCCCGGAAGTGGCGATC
CTCGGCGTGTCCAAGGCCAGCATGCAGCCGGTATGGGACGGCAAGGCCTTCCAGCCGCGC
CTGATGCTGCCGCTGTCGCTGTCCTACGATCACCGGGTGATCAACGGCGCCGCCGCGGCG
CGCTTCACCAAGCGTCTCGGCGACCTGCTGGCGGATATCCGCGCCATCCTGCTGTGA

# Drug_Target_24_General_Function:
Energy production and conversion

# Drug_Target_24_General_References:
1549782	Mattevi A, Obmolova G, Schulze E, Kalk KH, Westphal AH, de Kok A, Hol WG: Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. Science. 1992 Mar 20;255(5051):1544-50.
3191993	Hanemaaijer R, Vervoort J, Westphal AH, de Kok A, Veeger C: Mobile sequences in the pyruvate dehydrogenase complex, the E2 component, the catalytic domain and the 2-oxoglutarate dehydrogenase complex of Azotobacter vinelandii, as detected by 600 MHz 1H-NMR spectroscopy. FEBS Lett. 1988 Nov 21;240(1-2):205-10.
3292237	Hanemaaijer R, Janssen A, de Kok A, Veeger C: The dihydrolipoyltransacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Molecular cloning and sequence analysis. Eur J Biochem. 1988 Jul 1;174(4):593-9.
3691494	Hanemaaijer R, de Kok A, Jolles J, Veeger C: The domain structure of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1987 Dec 1;169(2):245-52.
8068086	Berg A, de Kok A, Vervoort J: Sequential 1H and 15N nuclear magnetic resonance assignments and secondary structure of the N-terminal lipoyl domain of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1994 Apr 1;221(1):87-100.
9119000	Berg A, Vervoort J, de Kok A: Three-dimensional structure in solution of the N-terminal lipoyl domain of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1997 Mar 1;244(2):352-60.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
2377

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
65045

# Drug_Target_24_Name:
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex

# Drug_Target_24_Number_of_Residues:
638

# Drug_Target_24_PDB_ID:
1DPD

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF00198	2-oxoacid_dh
PF00364	Biotin_lipoyl
PF02817	E3_binding

# Drug_Target_24_Protein_Sequence:
>Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSEIIRVPDIGGDGEVIELLVKTGDLIEVEQGLVVLESAKASMEVPSPKAGVVKSVSVKL
GDKLKEGDAIIELEPAAGAAAAPAEAAAVPAAPTQAVDEAEAPSPGASATPAPAAASQEV
RVPDIGSAGKARVIEVLVKAGDQVQAEQSLIVLESDKASMEIPSPASGVVESVAIQLNAE
VGTGDLILTLRTTGAQAQPTAPAAAAAASPAPAPLAPAAAGPQEVKVPDIGSAGKARVIE
VLVKAGDQVQAEQSLIVLESDKASMEIPSPAAGVVESVAVQLNAEVGTGDQILTLRVAGA
APSGPRARGSPGQAAAAPGAAPAPAPVGAPSRNGAKVHAGPAVRQLAREFGVELAAINST
GPRGRILKEDVQAYVKAMMQKAKEAPAAGAASGAGIPPIPPVDFAKYGEIEEVPMTRLMQ
IGATNLHRSWLNVPHVTQFESADITELEAFRVAQKAVAEKAGVKLTVLPLLLKACAYLLK
ELPDFNSSLAPSGQALIRKKYVHIGFAVDTPDGLLVPVIRNVDQKSLLQLAAEAAELAEK
ARSKKLGADAMQGACFTISSLGHIGGTAFTPIVNAPEVAILGVSKASMQPVWDGKAFQPR
LMLPLSLSYDHRVINGAAAARFTKRLGDLLADIRAILL

# Drug_Target_24_Reaction:
acetyl-CoA + enzyme N6-(dihydrolipoyl)lysine = CoA + enzyme N6-(S-acetyldihydrolipoyl)lysine

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple copies of three enzymatic components:pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3)

# Drug_Target_24_SwissProt_ID:
P10802

# Drug_Target_24_SwissProt_Name:
ODP2_AZOVI

# Drug_Target_24_Synonyms:
Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex
E2
EC 2.3.1.12

# Drug_Target_24_Theoretical_pI:
5.12

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
M36321

# Drug_Target_25_GenBank_ID_Protein:
147780

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
coaA

# Drug_Target_25_Gene_Sequence:
>1011 bp
GTGACGCGCCATGGCAAATATCGCTTTGCCGATAGAGCTATGACCGCCAGAAACATGCTT
ATGAGTATAAAAGAGCAAACGTTAATGACGCCTTACCTACAGTTTGACCGCAACCAGTGG
GCAGCTCTGCGTGATTCCGTACCTATGACGTTATCGGAAGATGAGATCGCCCGTCTCAAA
GGTATTAATGAAGATCTCTCGTTAGAAGAAGTTGCCGAGATCTATTTACCTTTGTCACGT
TTGCTGAACTTCTATATAAGCTCGAATCTGCGCCGTCAGGCAGTTCTGGAACAGTTTCTT
GGTACCAACGGGCAACGCATTCCTTACATTATCAGTATTGCTGGCAGTGTCGCGGTGGGG
AAAAGTACAACCGCCCGTGTATTGCAGGCGCTATTAAGCCGTTGGCCGGAACATCGTCGT
GTTGAACTGATCACTACAGATGGCTTCCTTCACCCTAATCAGGTTCTGAAAGAACGTGGT
CTGATGAAGAAGAAAGGCTTCCCGGAATCGTATGATATGCATCGCCTGGTGAAGTTTGTT
TCCGATCTCAAATCCGGCGTGCCAAACGTTACAGCACCTGTTTACTCACATCTTATTTAT
GATGTGATCCCGGATGGAGATAAAACGGTTGTTCAGCCTGATATTTTAATTCTTGAAGGG
TTAAATGTCTTACAGAGCGGGATGGATTATCCACACGATCCACATCATGTATTTGTTTCT
GATTTTGTCGATTTTTCGATATATGTTGATGCACCGGAAGACTTACTTCAGACATGGTAT
ATCAACCGTTTTCTGAAATTCCGCGAAGGGGCTTTTACCGACCCGGATTCCTATTTTCAT
AACTACGCGAAATTAACTAAAGAAGAAGCGATTAAGACTGCCATGACATTGTGGAAAGAG
ATCAACTGGCTGAACTTAAAGCAAAATATTCTACCTACTCGTGAGCGCGCCAGTTTAATC
CTGACGAAAAGTGCTAATCATGCGGTAGAAGAGGTCAGACTACGCAAATAA

# Drug_Target_25_General_Function:
Coenzyme transport and metabolism

# Drug_Target_25_General_References:
1311303	Song WJ, Jackowski S: coaA and rts are allelic and located at kilobase 3532 on the Escherichia coli physical map. J Bacteriol. 1992 Mar;174(5):1705-6.
1328157	Song WJ, Jackowski S: Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli. J Bacteriol. 1992 Oct;174(20):6411-7.
3073109	Flamm JA, Friesen JD, Otsuka AJ: The nucleotide sequence of the Escherichia coli rts gene. Gene. 1988 Dec 30;74(2):555-8.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
2371

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
36360

# Drug_Target_25_Name:
Pantothenate kinase

# Drug_Target_25_Number_of_Residues:
316

# Drug_Target_25_PDB_ID:
1SQ5

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF00485	PRK

# Drug_Target_25_Protein_Sequence:
>Pantothenate kinase
MSIKEQTLMTPYLQFDRNQWAALRDSVPMTLSEDEIARLKGINEDLSLEEVAEIYLPLSR
LLNFYISSNLRRQAVLEQFLGTNGQRIPYIISIAGSVAVGKSTTARVLQALLSRWPEHRR
VELITTDGFLHPNQVLKERGLMKKKGFPESYDMHRLVKFVSDLKSGVPNVTAPVYSHLIY
DVIPDGDKTVVQPDILILEGLNVLQSGMDYPHDPHHVFVSDFVDFSIYVDAPEDLLQTWY
INRFLKFREGAFTDPDSYFHNYAKLTKEEAIKTAMTLWKEINWLNLKQNILPTRERASLI
LTKSANHAVEEVRLRK

# Drug_Target_25_Reaction:
ATP + (R)-pantothenate = ADP + (R)-4'-phosphopantothenate

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
ATP + (R)-pantothenate = ADP + (R)-4'- phosphopantothenate

# Drug_Target_25_SwissProt_ID:
P0A6I3

# Drug_Target_25_SwissProt_Name:
COAA_ECOLI

# Drug_Target_25_Synonyms:
EC 2.7.1.33
Pantothenic acid kinase
Rts protein

# Drug_Target_25_Theoretical_pI:
6.81

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Not Available

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
Not Available

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
Not Available

# Drug_Target_26_GenBank_ID_Gene:
AE008771

# Drug_Target_26_GenBank_ID_Protein:
Not Available

# Drug_Target_26_GeneCard_ID:
Not Available

# Drug_Target_26_Gene_Name:
rimL

# Drug_Target_26_Gene_Sequence:
>540 bp
TTAATCCGCATCAATAATGCGGGCATACATATTAACGTCGTGATAGTCGCCGTTAAGATA
CTCCGCCTGCTTCATACAGCCCTCCAGCGTAAAATGGTTGCGCCGTGCGACTGCGTTACT
GGCCTGATTATCAACGCGGCATTTAATGACGAAGCGCCGAATATCGCCGCGCCGGGCATA
ATGTGTCATCAGCGCCTGTAATGATTGCGACATTATCCCTTGTCCCTGGAAGGACTCATC
CAGCCAGTAACCGATATAGGCGGCTTTGTTTATCGGTTCGATGGCATTAAATGAGAGTAC
GCCTGCCATCTCATTCTGGCAGAAAATCAGGTACATTTTGGCGTAACCACGCTGGTGCAA
CAGTATATTACCCTGCACATGCTTACGCGTTTCCTCCTGCGACGTGACATATTGCGGCCA
GTCGAGCGACTGTTGTAGCCACGCTTTGTTTTTGAGTACCAGTTGGTGCAGCGCCGGAAC
ATGACTTTCATCTGCCGCTCGCAGTTCCAGCGTCGTGCTAACAGGAATAATTTCCACCAT

# Drug_Target_26_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_26_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.

# Drug_Target_26_HGNC_ID:
Not Available

# Drug_Target_26_HPRD_ID:
Not Available

# Drug_Target_26_ID:
4563

# Drug_Target_26_Locus:
Not Available

# Drug_Target_26_Molecular_Weight:
20606

# Drug_Target_26_Name:
Acetyl transferase

# Drug_Target_26_Number_of_Residues:
179

# Drug_Target_26_PDB_ID:
1S7N

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_26_Protein_Sequence:
>Acetyl transferase
MVEIIPVSTTLELRAADESHVPALHQLVLKNKAWLQQSLDWPQYVTSQEETRKHVQGNIL
LHQRGYAKMYLIFCQNEMAGVLSFNAIEPINKAAYIGYWLDESFQGQGIMSQSLQALMTH
YARRGDIRRFVIKCRVDNQASNAVARRNHFTLEGCMKQAEYLNGDYHDVNMYARIIDAD

# Drug_Target_26_Reaction:
Not Available

# Drug_Target_26_Signals:
None

# Drug_Target_26_Specific_Function:
Not Available

# Drug_Target_26_SwissProt_ID:
Q8ZPC0

# Drug_Target_26_SwissProt_Name:
Q8ZPC0_SALTY

# Drug_Target_26_Synonyms:
EC 2.3.1.-

# Drug_Target_26_Theoretical_pI:
7.19

# Drug_Target_26_Transmembrane_Regions:
None

# Drug_Target_27_Cellular_Location:
Not Available

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
Not Available

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
Z99121

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
yvbK

# Drug_Target_27_Gene_Sequence:
>468 bp
ATGAATATGCAAAAGCTCAGGATTGAATTAGGAGAAGAAACAAATGACGAATTATATGAT
CTATTGCTGCTCGCCGATCCATCGAAAGACATTGTAGATGAATATCTTGAGAGGGGAGAA
TGTTACACAGCTTGGGCCGGTGATGAGCTTGCAGGGGTTTATGTATTGCTAAAAACAAGG
CCGCAAACAGTTGAAATTGTAAATATTGCGGTAAAAGAATCTCTTCAGAAGAAAGGCTTT
GGCAAACAGCTTGTACTTGACGCCATCGAAAAAGCGAAGAAGCTGGGGGCGGACACGATT
GAAATCGGAACGGGGAATTCGAGCATTCATCAGCTTTCCCTCTATCAAAAATGCGGATTC
CGCATTCAGGCGATCGACCACGATTTCTTTCTCAGACATTATGATGAGGACATTTTTGAA
AACGGGATTCAATGCCGCGATATGGTAAGGCTTTATTTGGATCTCTGA

# Drug_Target_27_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_27_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_27_HGNC_ID:
Not Available

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
4564

# Drug_Target_27_Locus:
Not Available

# Drug_Target_27_Molecular_Weight:
17746

# Drug_Target_27_Name:
YvbK protein

# Drug_Target_27_Number_of_Residues:
155

# Drug_Target_27_PDB_ID:
1YVK

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_27_Protein_Sequence:
>YvbK protein
MNMQKLRIELGEETNDELYDLLLLADPSKDIVDEYLERGECYTAWAGDELAGVYVLLKTR
PQTVEIVNIAVKESLQKKGFGKQLVLDAIEKAKKLGADTIEIGTGNSSIHQLSLYQKCGF
RIQAIDHDFFLRHYDEDIFENGIQCRDMVRLYLDL

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
Not Available

# Drug_Target_27_SwissProt_ID:
O32248

# Drug_Target_27_SwissProt_Name:
YVBK_BACSU

# Drug_Target_27_Synonyms:
Not Available

# Drug_Target_27_Theoretical_pI:
4.49

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Not Available

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
Not Available

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
Not Available

# Drug_Target_28_GenBank_ID_Gene:
AF144881

# Drug_Target_28_GenBank_ID_Protein:
Not Available

# Drug_Target_28_GeneCard_ID:
Not Available

# Drug_Target_28_Gene_Name:
aac(6')-Iy

# Drug_Target_28_Gene_Sequence:
>438 bp
ATGGACATCAGGCAAATGAACAAAACCCATCTGGAGCACTGGCGCGGATTGCGAAAACAG
CTCTGGCCTGGTCACCCGGATGACGCCCATCTGGCGGACGGCGAAGAAATTCTGCAAGCC
GATCATCTGGCATCATTTATTGCGATGGCAGACGGGGTGGCGATTGGCTTTGCGGATGCC
TCAATCCGCCACGATTATGTCAATGGCTGTGACAGTTCGCCCGTGGTTTTCCTTGAAGGT
ATTTTTGTTCTCCCCTCATTCCGTCAACGCGGCGTAGCGAAACAATTGATTGCAGCGGTG
CAACGATGGGGAACGAATAAAGGGTGTCGGGAAATGGCCTCCGATACCTCGCCGGAAAAT
ACAATTTCCCAGAAAGTTCATCAGGCGTTAGGATTTGAGGAAACAGAGCGCGTCATTTTC
TACCGAAAGCGTTGTTGA

# Drug_Target_28_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_28_General_References:
10542165	Magnet S, Courvalin P, Lambert T: Activation of the cryptic aac(6')-Iy aminoglycoside resistance gene of Salmonella by a chromosomal deletion generating a transcriptional fusion. J Bacteriol. 1999 Nov;181(21):6650-5.

# Drug_Target_28_HGNC_ID:
Not Available

# Drug_Target_28_HPRD_ID:
Not Available

# Drug_Target_28_ID:
4565

# Drug_Target_28_Locus:
Not Available

# Drug_Target_28_Molecular_Weight:
16362

# Drug_Target_28_Name:
Aminoglycoside 6'-N-acetyltransferase

# Drug_Target_28_Number_of_Residues:
145

# Drug_Target_28_PDB_ID:
1S60

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_28_Protein_Sequence:
>Aminoglycoside 6'-N-acetyltransferase
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC

# Drug_Target_28_Reaction:
Not Available

# Drug_Target_28_Signals:
None

# Drug_Target_28_Specific_Function:
Not Available

# Drug_Target_28_SwissProt_ID:
Q9R381

# Drug_Target_28_SwissProt_Name:
Q9R381_SALEN

# Drug_Target_28_Synonyms:
Not Available

# Drug_Target_28_Theoretical_pI:
6.88

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Not Available

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
Not Available

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
AE016877

# Drug_Target_29_GenBank_ID_Protein:
Not Available

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
BC_2038

# Drug_Target_29_Gene_Sequence:
>516 bp
GTGATAACAATGACAGAAGTAAAGGGGAAAACAGCCAATGAGTCAAGGGTGTTCAAAACG
AGCCGAGTATTCCCAACAGATTTAAATGATCATAACACGCTATTTGGTGGGAAGATATTA
TCGGAGATGGATATGGTTGCTTCTATTTCAGCATCCAGACATTCGAGAAAGGAATGTGTC
ACAGCATCTATGGACTGGGTCGATTTCTTACATCCTGTTCGTTCTTCAGATTGTGTTAGT
TATGAATCTTTCGTAATTTGGACGGGAAGAACTTCGATGGAAGTGTTTGTGAAGGTAGTA
TCTGAATATTTAATTTCAGGTGAGAAGCGTATAGCGGCAACGTCATTCGTTACTTTTGTG
GCACTTAGTAAGGAAAATAATCCAGTTCCAGTACCGCGTGTTATCCCTGACACAGAAGAA
GAGAAAGAATCACATCGTATTGCTGTGTTACGTGCAGAACAGCGTCATATACGTAAGGCA
GAGAGTAAGAAAGTAGCCACATTGTTAACCTTTTGA

# Drug_Target_29_General_Function:
Lipid transport and metabolism

# Drug_Target_29_General_References:
12721630	Ivanova N, Sorokin A, Anderson I, Galleron N, Candelon B, Kapatral V, Bhattacharyya A, Reznik G, Mikhailova N, Lapidus A, Chu L, Mazur M, Goltsman E, Larsen N, D'Souza M, Walunas T, Grechkin Y, Pusch G, Haselkorn R, Fonstein M, Ehrlich SD, Overbeek R, Kyrpides N: Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature. 2003 May 1;423(6935):87-91.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
4566

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
19313

# Drug_Target_29_Name:
Acyl-CoA hydrolase

# Drug_Target_29_Number_of_Residues:
171

# Drug_Target_29_PDB_ID:
1Y7U

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF03061	4HBT

# Drug_Target_29_Protein_Sequence:
>Acyl-CoA hydrolase
MITMTEVKGKTANESRVFKTSRVFPTDLNDHNTLFGGKILSEMDMVASISASRHSRKECV
TASMDWVDFLHPVRSSDCVSYESFVIWTGRTSMEVFVKVVSEYLISGEKRIAATSFVTFV
ALSKENNPVPVPRVIPDTEEEKESHRIAVLRAEQRHIRKAESKKVATLLTF

# Drug_Target_29_Reaction:
Not Available

# Drug_Target_29_Signals:
None

# Drug_Target_29_Specific_Function:
Not Available

# Drug_Target_29_SwissProt_ID:
Q81EE4

# Drug_Target_29_SwissProt_Name:
Q81EE4_BACCR

# Drug_Target_29_Synonyms:
EC 3.1.2.20

# Drug_Target_29_Theoretical_pI:
8.73

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
DBI

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6986

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
Not Available

# Drug_Target_2_Name:
Acyl-CoA-binding protein

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P07108

# Drug_Target_2_SwissProt_Name:
ACBP_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
Not Available

# Drug_Target_30_Cellular_Location:
Not Available

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
Not Available

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
L42023

# Drug_Target_30_GenBank_ID_Protein:
Not Available

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
HI_0827

# Drug_Target_30_Gene_Sequence:
>465 bp
ATGTCTGCCAATTTTACTGATAAAAATGGTCGCCAATCAAAAGGAGTTCTTTTACTACGA
ACTTTGGCGATGCCTTCTGACACCAATGCTAACGGAGATATTTTTGGTGGCTGGATTATG
TCTCAAATGGATATGGGCGGCGCGATTTTAGCGAAAGAAATCGCACACGGACGCGTGGTT
ACTGTCGCCGTTGAAAGTATGAATTTTATCAAACCAATCTCTGTGGGCGATGTGGTTTGT
TGCTACGGTCAATGTCTCAAAGTTGGGCGTTCTTCCATTAAAATTAAAGTAGAAGTATGG
GTAAAAAAAGTGGCGAGTGAGCCAATTGGCGAACGTTATTGTGTCACCGATGCGGTATTT
ACTTTTGTTGCAGTTGATAATAATGGTCGCTCTCGCACGATTCCCCGTGAAAATAACCAA
GAGTTAGAAAAAGCATTAGCCTTAATTTCAGAACAACCCTTGTAA

# Drug_Target_30_General_Function:
Lipid transport and metabolism

# Drug_Target_30_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
4567

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
16764

# Drug_Target_30_Name:
Putative acyl-CoA thioester hydrolase HI0827

# Drug_Target_30_Number_of_Residues:
154

# Drug_Target_30_PDB_ID:
1YLI

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF03061	4HBT

# Drug_Target_30_Protein_Sequence:
>Putative acyl-CoA thioester hydrolase HI0827
MSANFTDKNGRQSKGVLLLRTLAMPSDTNANGDIFGGWIMSQMDMGGAILAKEIAHGRVV
TVAVESMNFIKPISVGDVVCCYGQCLKVGRSSIKIKVEVWVKKVASEPIGERYCVTDAVF
TFVAVDNNGRSRTIPRENNQELEKALALISEQPL

# Drug_Target_30_Reaction:
Not Available

# Drug_Target_30_Signals:
None

# Drug_Target_30_Specific_Function:
Not Available

# Drug_Target_30_SwissProt_ID:
P44886

# Drug_Target_30_SwissProt_Name:
Y827_HAEIN

# Drug_Target_30_Synonyms:
EC 3.1.2.-

# Drug_Target_30_Theoretical_pI:
8.33

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
Not Available

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
Not Available

# Drug_Target_31_GenBank_ID_Gene:
AF293442

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
fabH

# Drug_Target_31_Gene_Sequence:
>1020 bp
ATGCCCGGACTTCGGGTTCCCGAGCGGCGTTTCAGCCGTGTTCTCGGGGTCGGTTCGTAC
CGGCCCCGCCGTGAGGTGAGCAACAAGGAGGTGTGCACCTGGATCGACTCGACGGAGGAG
TGGATCGAGACGCGCACCGGGATCAGGTCGCGGCGGATCGCCGAGCCGGACGAGACGATC
CAGGTGATGGGGGTGGCCGCGAGCCGCCGCGCGCTGGAGCACGCCGGCGTGGATCCGGCC
GAGATCGACCTGGTCGTGGTCTCCACGATGACCAACTTCGTGCACACGCCGCCGCTTTCG
GTCGCGATCGCGCACGAGCTGGGTGCCGACAACGCCGGCGGGTTCGACCTGTCGGCGGCG
TGCGCGGGGTTCTGCCACGCGTTGTCGATCGCGGCGGACGCGGTGGAGTCCGGCGGTTCG
CGGCACGTGCTCGTGGTGGCGACGGAGCGGATGACCGACGTGATCGACCTGGCGGACCGG
AGCCTGTCGTTCCTGTTCGGCGACGGCGCCGGCGCGGCCGTGGTCGGCCCGTCCGACGTG
CCCGGCATCGGTCCGGTGGTGCGCGGCATCGACGGCACCGGCCTGGGCTCGCTGCACATG
AGCAGTTCGTGGGACCAGTACGTCGAGGACCCCTCGGTGGGCCGGCCGGCGCTGGTGATG
GACGGCAAGCGGGTGTTCCGCTGGGCGGTCGCGGACGTCGTCCCGGCGGCCCGCGAGGCG
CTCGAGGTGGCCGGCCTGACCGTCGGGGACCTGGTGGCGTTCGTCCCGCACCAGGCCAAC
CTGCGGATCATCGACGTGCTGGTGGACCGGCTCGGCGTGCCGGAGCACGTGGTCGTCTCG
CGCGACGCGGAGGACACCGGCAACACCTCGTCGGCGTCGGTGGCCCTGGCCCTGGACCGG
CTGGTGCGCTCCGGCGCGGTGCCCGGCGGCGGGCCCGCGCTGATGATCGGTTTCGGCGCC
GGGCTGAGCTACGCGGGCCAGGCTCTACTGCTTCCCGACCCGCCGTCCACTCCGGCTTGA

# Drug_Target_31_General_Function:
Involved in 3-oxoacyl-[acyl-carrier-protein] synthase activity

# Drug_Target_31_General_References:
10931852	Marti T, Hu Z, Pohl NL, Shah AN, Khosla C: Cloning, nucleotide sequence, and heterologous expression of the biosynthetic gene cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into an unusual priming mechanism. J Biol Chem. 2000 Oct 27;275(43):33443-8.
11732905	Meadows ES, Khosla C: In vitro reconstitution and analysis of the chain initiating enzymes of the R1128 polyketide synthase. Biochemistry. 2001 Dec 11;40(49):14855-61.
12429097	Pan H, Tsai S, Meadows ES, Miercke LJ, Keatinge-Clay AT, O'Connell J, Khosla C, Stroud RM: Crystal structure of the priming beta-ketosynthase from the R1128 polyketide biosynthetic pathway. Structure. 2002 Nov;10(11):1559-68.

# Drug_Target_31_HGNC_ID:
Not Available

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
4568

# Drug_Target_31_Locus:
Not Available

# Drug_Target_31_Molecular_Weight:
35392

# Drug_Target_31_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 3

# Drug_Target_31_Number_of_Residues:
339

# Drug_Target_31_PDB_ID:
1MZJ

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF08541	ACP_syn_III_C
PF08545	ACP_syn_III

# Drug_Target_31_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 3
MPGLRVPERRFSRVLGVGSYRPRREVSNKEVCTWIDSTEEWIETRTGIRSRRIAEPDETI
QVMGVAASRRALEHAGVDPAEIDLVVVSTMTNFVHTPPLSVAIAHELGADNAGGFDLSAA
CAGFCHALSIAADAVESGGSRHVLVVATERMTDVIDLADRSLSFLFGDGAGAAVVGPSDV
PGIGPVVRGIDGTGLGSLHMSSSWDQYVEDPSVGRPALVMDGKRVFRWAVADVVPAAREA
LEVAGLTVGDLVAFVPHQANLRIIDVLVDRLGVPEHVVVSRDAEDTGNTSSASVALALDR
LVRSGAVPGGGPALMIGFGAGLSYAGQALLLPDPPSTPA

# Drug_Target_31_Reaction:
Not Available

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate preference for butyryl-CoA and can tolerate branched substrates. Can also prime acyl-CoA. Its substrate specificity determines the biosynthesis of branched-chain and/or straight-chain of fatty acids. Involved in the biosynthesis of R1128 polyketide

# Drug_Target_31_SwissProt_ID:
Q9F6D4

# Drug_Target_31_SwissProt_Name:
FABH_STRLI

# Drug_Target_31_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase III
Beta-ketoacyl-ACP synthase III
EC 2.3.1.41
KAS III

# Drug_Target_31_Theoretical_pI:
4.77

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Not Available

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
Not Available

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
BX842574

# Drug_Target_32_GenBank_ID_Protein:
Not Available

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
mshD

# Drug_Target_32_Gene_Sequence:
>948 bp
GTGACGGCGCTTGACTGGCGCTCCGCTCTGACCGCCGACGAGCAGCGCAGCGTGCGTGCA
CTGGTCACGGCGACAACAGCAGTCGATGGGGTAGCACCCGTGGGTGAACAGGTGCTGCGG
GAACTGGGCCAGCAACGCACCGAGCATCTGCTGGTGGCCGGTTCGCGACCGGGCGGCCCG
ATCATCGGCTACCTCAACCTCAGCCCACCCCGGGGCGCGGGTGGTGCGATGGCGGAGTTG
GTGGTGCATCCGCAGTCTCGACGGCGCGGTATCGGCACCGCCATGGCCCGCGCGGCATTG
GCCAAGACCGCCGGCCGCAACCAGTTCTGGGCGCACGGCACGCTGGATCCCGCTCGGGCG
ACCGCGTCCGCGCTGGGTCTGGTCGGCGTCCGCGAACTGATCCAGATGCGACGCCCGCTG
CGTGATATCCCCGAACCGACGATCCCCGACGGGGTGGTGATCCGCACCTACGCGGGCACG
TCCGACGACGCTGAGCTACTCCGGGTCAACAACGCCGCGTTCGCCGGACACCCGGAACAG
GGTGGGTGGACCGCGGTCCAGCTTGCCGAGCGGCGTGGCGAGGCGTGGTTCGATCCAGAC
GGCCTGATCTTGGCCTTCGGTGATTCGCCACGTGAACGGCCTGGCCGGTTGCTGGGTTTC
CATTGGACCAAAGTGCATCCCGATCACCCGGGATTGGGCGAGGTGTACGTGCTGGGCGTC
GATCCGGCGGCGCAGCGCCGCGGTCTCGGCCAGATGTTGACGTCGATCGGTATCGTCTCG
CTGGCCCGTCGGCTGGGCGGTCGGAAGACCCTCGACCCTGCGGTCGAACCCGCCGTGCTG
CTCTACGTGGAGTCGGACAATGTGGCGGCCGTGCGAACCTACCAGAGCCTGGGCTTCACC
ACCTACAGCGTCGATACCGCCTACGCGCTGGCTGGCACGGATAACTGA

# Drug_Target_32_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_32_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
12368430	Camus JC, Pryor MJ, Medigue C, Cole ST: Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology. 2002 Oct;148(Pt 10):2967-73.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_32_HGNC_ID:
Not Available

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
4569

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
33600

# Drug_Target_32_Name:
Hypothetical protein

# Drug_Target_32_Number_of_Residues:
315

# Drug_Target_32_PDB_ID:
1P0H

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_32_Protein_Sequence:
>Hypothetical protein
MTALDWRSALTADEQRSVRALVTATTAVDGVAPVGEQVLRELGQQRTEHLLVAGSRPGGP
IIGYLNLSPPRGAGGAMAELVVHPQSRRRGIGTAMARAALAKTAGRNQFWAHGTLDPARA
TASALGLVGVRELIQMRRPLRDIPEPTIPDGVVIRTYAGTSDDAELLRVNNAAFAGHPEQ
GGWTAVQLAERRGEAWFDPDGLILAFGDSPRERPGRLLGFHWTKVHPDHPGLGEVYVLGV
DPAAQRRGLGQMLTSIGIVSLARRLGGRKTLDPAVEPAVLLYVESDNVAAVRTYQSLGFT
TYSVDTAYALAGTDN

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
None

# Drug_Target_32_Specific_Function:
Not Available

# Drug_Target_32_SwissProt_ID:
O53831

# Drug_Target_32_SwissProt_Name:
MSHD_MYCTU

# Drug_Target_32_Synonyms:
Not Available

# Drug_Target_32_Theoretical_pI:
8.84

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Not Available

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
Not Available

# Drug_Target_33_GenBank_ID_Protein:
Not Available

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
KAT2A

# Drug_Target_33_Gene_Sequence:
Not Available

# Drug_Target_33_General_Function:
Not Available

# Drug_Target_33_General_References:
Not Available

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
7093

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
Not Available

# Drug_Target_33_Name:
Histone acetyltransferase KAT2A

# Drug_Target_33_Number_of_Residues:
0

# Drug_Target_33_PDB_ID:
Not Available

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
Not Available

# Drug_Target_33_Protein_Sequence:
Not Available

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
Not Available

# Drug_Target_33_Specific_Function:
Not Available

# Drug_Target_33_SwissProt_ID:
Q92830

# Drug_Target_33_SwissProt_Name:
KAT2A_HUMAN

# Drug_Target_33_Synonyms:
Not Available

# Drug_Target_33_Theoretical_pI:
Not Available

# Drug_Target_33_Transmembrane_Regions:
Not Available

# Drug_Target_34_Cellular_Location:
Not Available

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
Not Available

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
BA000004

# Drug_Target_34_GenBank_ID_Protein:
Not Available

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
BH0798

# Drug_Target_34_Gene_Sequence:
>474 bp
ATGATCCAATCTTATCCGGTTGAACGATCAAGAACGATACAAACGAGGCTCGTATTACCA
CCAGATACGAATCATCTAGGGACGATTTTTGGTGGGAAAGTTCTCGCATATATCGATGAA
ATAGCTGCTTTAACAGCGATGAAGCATGCTAATTCTGCGGTGGTTACTGCTTCAATCGAT
TCTGTTGACTTTAAGTCGTCGGCTACTGTGGGTGATGCCCTTGAACTTGAAGGGTTTGTC
ACACATACAGGAAGAACGTCGATGGAAGTATATGTGAGGGTTCATTCGAACAACTTATTG
ACAGGAGAACGGACGTTAACAACCGAGTCGTTTCTAACGATGGTCGCCGTTGACGAATCA
GGTAAACCAAAACCAGTGCCCCAGGTCGAGCCTCAGACCGAAGAGGAAAAACGGCTATAC
GAAACCGCGCCTGCACGAAAAGAAAACCGGAAAAAACGAGCAGCCTTAAGATAA

# Drug_Target_34_General_Function:
Lipid transport and metabolism

# Drug_Target_34_General_References:
11058132	Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K: Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Res. 2000 Nov 1;28(21):4317-31.

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
4572

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
17328

# Drug_Target_34_Name:
Acyl-CoA hydrolase

# Drug_Target_34_Number_of_Residues:
157

# Drug_Target_34_PDB_ID:
1VPM

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
PF03061	4HBT

# Drug_Target_34_Protein_Sequence:
>Acyl-CoA hydrolase
MIQSYPVERSRTIQTRLVLPPDTNHLGTIFGGKVLAYIDEIAALTAMKHANSAVVTASID
SVDFKSSATVGDALELEGFVTHTGRTSMEVYVRVHSNNLLTGERTLTTESFLTMVAVDES
GKPKPVPQVEPQTEEEKRLYETAPARKENRKKRAALR

# Drug_Target_34_Reaction:
Not Available

# Drug_Target_34_Signals:
None

# Drug_Target_34_Specific_Function:
Not Available

# Drug_Target_34_SwissProt_ID:
Q9KEQ1

# Drug_Target_34_SwissProt_Name:
Q9KEQ1_BACHD

# Drug_Target_34_Synonyms:
Not Available

# Drug_Target_34_Theoretical_pI:
7.84

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Nucleus (By similarity)

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
Not Available

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
PCAF

# Drug_Target_35_GenBank_ID_Gene:
U57317

# Drug_Target_35_GenBank_ID_Protein:
Not Available

# Drug_Target_35_GeneCard_ID:
Not Available

# Drug_Target_35_Gene_Name:
KAT2B

# Drug_Target_35_Gene_Sequence:
>2499 bp
ATGTCCGAGGCTGGCGGGGCCGGGCCGGGCGGCTGCGGGGCAGGAGCCGGGGCAGGGGCC
GGGCCCGGGGCGCTGCCCCCGCAGCCTGCGGCGCTTCCGCCCGCGCCCCCGCAGGGCTCC
CCCTGCGCCGCTGCCGCCGGGGGCTCGGGCGCCTGCGGTCCGGCGACGGCAGTGGCTGCA
GCGGGCACGGCCGAAGGACCGGGAGGCGGTGGCTCGGCCCGAATCGCCGTGAAGAAAGCG
CAACTACGCTCCGCTCCGCGGGCCAAGAAACTGGAGAAACTCGGAGTGTACTCCGCCTGC
AAGGCCGAGGAGTCTTGTAAATGTAATGGCTGGAAAAACCCTAACCCCTCACCCACTCCC
CCCAGAGCCGACCTGCAGCAAATAATTGTCAGTCTAACAGAATCCTGTCGGAGTTGTAGC
CATGCCCTAGCTGCTCATGTTTCCCACCTGGAGAATGTGTCAGAGGAAGAAATGAACAGA
CTCCTGGGAATAGTATTGGATGTGGAATATCTCTTTACCTGTGTCCACAAGGAAGAAGAT
GCAGATACCAAACAAGTTTATTTCTATCTATTTAAGCTCTTGAGAAAGTCTATTTTACAA
AGAGGAAAACCTGTGGTTGAAGGCTCTTTGGAAAAGAAACCCCCATTTGAAAAACCTAGC
ATTGAACAGGGTGTGAATAACTTTGTGCAGTACAAATTTAGTCACCTGCCAGCAAAAGAA
AGGCAAACAATAGTTGAGTTGGCAAAAATGTTCCTAAACCGCATCAACTATTGGCATCTG
GAGGCACCATCTCAACGAAGACTGCGATCTCCCAATGATGATATTTCTGGATACAAAGAG
AACTACACAAGGTGGCTGTGTTACTGCAACGTGCCACAGTTCTGCGACAGTCTACCTCGG
TACGAAACCACACAGGTGTTTGGGAGAACATTGCTTCGCTCGGTCTTCACTGTTATGAGG
CGACAACTCCTGGAACAAGCAAGACAGGAAAAAGATAAACTGCCTCTTGAAAAACGAACT
CTAATCCTCACTCATTTCCCAAAATTTCTGTCCATGCTAGAAGAAGAAGTATATAGTCAA
AACTCTCCCATCTGGGATCAGGATTTTCTCTCAGCCTCTTCCAGAACCAGCCAGCTAGGC
ATCCAAACAGTTATCAATCCACCTCCTGTGGCTGGGACAATTTCATACAATTCAACCTCA
TCTTCCCTTGAGCAGCCAAACGCAGGGAGCAGCAGTCCTGCCTGCAAAGCCTCTTCTGGA
CTTGAGGCAAACCCAGGAGAAAAGAGGAAAATGACTGATTCTCATGTTCTGGAGGAGGCC
AAGAAACCCCGAGTTATGGGGGATATTCCGATGGAATTAATCAACGAGGTTATGTCTACC
ATCACGGACCCTGCAGCAATGCTTGGACCAGAGACCAATTTTCTGTCAGCACACTCGGCC
AGGGATGAGGCGGCAAGGTTGGAAGAGCGCAGGGGTGTAATTGAATTTCACGTGGTTGGC
AATTCCCTCAACCAGAAACCAAACAAGAAGATCCTGATGTGGCTGGTTGGCCTACAGAAC
GTTTTCTCCCACCAGCTGCCCCGAATGCCAAAAGAATACATCACACGGCTCGTCTTTGAC
CCGAAACACAAAACCCTTGCTTTAATTAAAGATGGCCGTGTTATTGGTGGTATCTGTTTC
CGTATGTTCCCATCTCAAGGATTCACAGAGATTGTCTTCTGTGCTGTAACCTCAAATGAG
CAAGTCAAGGGCTATGGAACACACCTGATGAATCATTTGAAAGAATATCACATAAAGCAT
GACATCCTGAACTTCCTCACATATGCAGATGAATATGCAATTGGATACTTTAAGAAACAG
GGTTTCTCCAAAGAAATTAAAATACCTAAAACCAAATATGTTGGCTATATCAAGGATTAT
GAAGGAGCCACTTTAATGGGATGTGAGCTAAATCCACGGATCCCGTACACAGAATTTTCT
GTCATCATTAAAAAGCAGAAGGAGATAATTAAAAAACTGATTGAAAGAAAACAGGCACAA
ATTCGAAAAGTTTACCCTGGACTTTCATGTTTTAAAGATGGAGTTCGACAGATTCCTATA
GAAAGCATTCCTGGAATTAGAGAGACAGGCTGGAAACCGAGTGGAAAAGAGAAAAGTAAA
GAGCCCAGAGACCCTGACCAGCTTTACAGCACGCTCAAGAGCATCCTCCAGCAGGTGAAG
AGCCATCAAAGCGCTTGGCCCTTCATGGAACCTGTGAAGAGAACAGAAGCTCCAGGATAT
TATGAAGTTATAAGGTTCCCCATGGATCTGAAAACCATGAGTGAACGCCTCAAGAATAGG
TACTACGTGTCTAAGAAATTATTCATGGCAGACTTACAGCGAGTCTTTACCAATTGCAAA
GAGTACAACGCCGCTGAGAGTGAATACTACAAATGTGCCAATATCCTGGAGAAATTCTTC
TTCAGTAAAATTAAGGAAGCTGGATTAATTGACAAGTGA

# Drug_Target_35_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_35_General_References:
10365964	Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM: Structure and ligand of a histone acetyltransferase bromodomain. Nature. 1999 Jun 3;399(6735):491-6.
8684459	Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996 Jul 25;382(6589):319-24.
8945521	Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996 Nov 29;87(5):953-9.
9346901	Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW: TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem. 1997 Oct 31;272(44):27629-34.

# Drug_Target_35_HGNC_ID:
HGNC:8638

# Drug_Target_35_HPRD_ID:
Not Available

# Drug_Target_35_ID:
4573

# Drug_Target_35_Locus:
3p24

# Drug_Target_35_Molecular_Weight:
93014

# Drug_Target_35_Name:
Histone acetyltransferase PCAF

# Drug_Target_35_Number_of_Residues:
832

# Drug_Target_35_PDB_ID:
1CM0

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
PF00439	Bromodomain
PF00583	Acetyltransf_1
PF06466	PCAF_N

# Drug_Target_35_Protein_Sequence:
>Histone acetyltransferase PCAF
MSEAGGAGPGGCGAGAGAGAGPGALPPQPAALPPAPPQGSPCAAAAGGSGACGPATAVAA
AGTAEGPGGGGSARIAVKKAQLRSAPRAKKLEKLGVYSACKAEESCKCNGWKNPNPSPTP
PRADLQQIIVSLTESCRSCSHALAAHVSHLENVSEEEMNRLLGIVLDVEYLFTCVHKEED
ADTKQVYFYLFKLLRKSILQRGKPVVEGSLEKKPPFEKPSIEQGVNNFVQYKFSHLPAKE
RQTIVELAKMFLNRINYWHLEAPSQRRLRSPNDDISGYKENYTRWLCYCNVPQFCDSLPR
YETTQVFGRTLLRSVFTVMRRQLLEQARQEKDKLPLEKRTLILTHFPKFLSMLEEEVYSQ
NSPIWDQDFLSASSRTSQLGIQTVINPPPVAGTISYNSTSSSLEQPNAGSSSPACKASSG
LEANPGEKRKMTDSHVLEEAKKPRVMGDIPMELINEVMSTITDPAAMLGPETNFLSAHSA
RDEAARLEERRGVIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFD
PKHKTLALIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKH
DILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTEFS
VIIKKQKEIIKKLIERKQAQIRKVYPGLSCFKDGVRQIPIESIPGIRETGWKPSGKEKSK
EPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNR
YYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK

# Drug_Target_35_Reaction:
Not Available

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
Functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Has significant histone acetyltransferase activity with core histones (H3 and H4), and also with nucleosome core particles. Inhibits cell-cycle progression and counteracts the mitogenic activity of the adenoviral oncoprotein E1A. In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes

# Drug_Target_35_SwissProt_ID:
Q92831

# Drug_Target_35_SwissProt_Name:
KAT2B_HUMAN

# Drug_Target_35_Synonyms:
EC 2.3.1.48
Histone acetylase PCAF
P/CAF
P300/CBP-associated factor

# Drug_Target_35_Theoretical_pI:
9.37

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Not Available

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
Not Available

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
Not Available

# Drug_Target_36_GenBank_ID_Gene:
BX842573

# Drug_Target_36_GenBank_ID_Protein:
Not Available

# Drug_Target_36_GeneCard_ID:
Not Available

# Drug_Target_36_Gene_Name:
menB

# Drug_Target_36_Gene_Sequence:
>945 bp
TTAGAAATAGCGCGGAAACGGGCTCCAGTCGGGGGGACGCTTCTGTAGGAAGGCGTCGCG
GCCTTCGACGGCCTCGTCGGTCATGTAGGCCAGGCGGGTGGCCTCACCGGCAAACAGTTG
CTGACCCACCAGCCCGTCGTCGAGCAGGTTGAACGCGAACTTCAGCATCCGTTGCGCCTG
AGGCGATTTCGCGTTGATCTCGGCCGCCCACTGCAGCCCCACTGTCTCCAGCTCGGCGTG
TTCGGCCACCGCGTTGACCGCGCCCATCTGGTGCATCTGCTCGGCGGTGTAGGTGCGGCC
TAGGAAGAAGATCTCGCGGGCAAACTTCTGGCCGACCTGACGGGCCAGATATGCGCTGCC
GTAACCGCCATCGAAGCTGCCGACGTCGGCGTCGGTCTGCTTGAAGCGGGCGTACTCGCG
GCTGGCCAGGGTGAGATCGCAGACCACGTGCAGGCTGTGTCCCCCGCCGGCCGCCCAGCC
ATTGACCAGACAAATGACCACCTTGGGCATGAACCGGATCAGCCGCTGCACCTCCAGGAT
GTGCAACCGGCCGGCGCGGGCGACATCAACCGTGTCCGCGGTGTCTCCGCTGGCGTACTG
GTAACCGCTGCGCCCACGAATTCGTTGGTCGCCGCCGGAGCAGAACGCCCAGCCGCCGTC
CTTCGGGGACGGCCCGTTGCCGGTCAGCAGCACCACTCCGACGTCGGGCGACATTCGTGC
ATGGTCGAGCACCCGGTACAGCTCGTCGACGGTGTGCGGGCGAAATGCGTTGCGCACTTC
AGGGCGGTTGAACGCCACCCGCACCGTGGCATCGTCGACGTGGCGGTGGTAGGTGATGTC
GGTCAGATCGTCGAACCCGTCCACGAGCCGCCACGCCTTGGCATCAAAAGGGTTGTCACT
CAAGGCTGTTGAACTCCGTCCTTGTTCGCCGGCTGGAGCCACCAC

# Drug_Target_36_General_Function:
Involved in catalytic activity

# Drug_Target_36_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_36_HGNC_ID:
Not Available

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
4574

# Drug_Target_36_Locus:
Not Available

# Drug_Target_36_Molecular_Weight:
34689

# Drug_Target_36_Name:
PROBABLE NAPHTHOATE SYNTHASE MENB

# Drug_Target_36_Number_of_Residues:
314

# Drug_Target_36_PDB_ID:
1Q52

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00378	ECH

# Drug_Target_36_Protein_Sequence:
>PROBABLE NAPHTHOATE SYNTHASE MENB
MVAPAGEQGRSSTALSDNPFDAKAWRLVDGFDDLTDITYHRHVDDATVRVAFNRPEVRNA
FRPHTVDELYRVLDHARMSPDVGVVLLTGNGPSPKDGGWAFCSGGDQRIRGRSGYQYASG
DTADTVDVARAGRLHILEVQRLIRFMPKVVICLVNGWAAGGGHSLHVVCDLTLASREYAR
FKQTDADVGSFDGGYGSAYLARQVGQKFAREIFFLGRTYTAEQMHQMGAVNAVAEHAELE
TVGLQWAAEINAKSPQAQRMLKFAFNLLDDGLVGQQLFAGEATRLAYMTDEAVEGRDAFL
QKRPPDWSPFPRYF

# Drug_Target_36_Reaction:
Not Available

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Not Available

# Drug_Target_36_SwissProt_ID:
O06414

# Drug_Target_36_SwissProt_Name:
MENB_MYCTU

# Drug_Target_36_Synonyms:
DHNA SYNTHETASE
DIHYDROXYNAPHTHOIC ACID SYNTHETASE
EC 4.1.3.36
Naphthoate synthase

# Drug_Target_36_Theoretical_pI:
6.42

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Not Available

# Drug_Target_37_Chromosome_Location:
Not Available

# Drug_Target_37_Drug_References:
Not Available

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
Not Available

# Drug_Target_37_GenBank_ID_Gene:
AB040146

# Drug_Target_37_GenBank_ID_Protein:
Not Available

# Drug_Target_37_GeneCard_ID:
Not Available

# Drug_Target_37_Gene_Name:
cit

# Drug_Target_37_Gene_Sequence:
>1134 bp
ATGGAAGTGGCACGCGGTCTGGAAGGCGTTCTCTTCACGGAAAGCCGGATGTGCTACATT
GACGGCCAGCAGGGGAAGCTCTACTACTACGGCATTCCCATCCAGGAGCTGGCGGAGAAG
AGCAGCTTTGAGGAAACCACCTTCCTCCTCCTCCACGGGAGACTGCCGCGAAGGCAGGAG
CTGGAGGAGTTCTCGGCCGCCCTCGCCCGGCGCCGCGCCATGCCCGCCCACCTTCTGGAG
TCCTTCAAGCGCTACCCCGTCTCCGCCCACCCCATGAGCTTCCTGCGCACGGCGGTCTCC
GAGTTCGGGATGCTGGACCCCACCGAGGGGGACATCTCCCGGGAGGCCCTCTACGAGAAG
GGGCTTGACCTCATCGCCAAGTTCGCCACCATCGTGGCCGCCAACAAGCGCCTCAAGGAG
GGCAAGGAGCCCATCCCTCCCCGGGAGGACCTCTCCCACGCCGCCAACTTCCTCTACATG
GCGAACGGGGTGGAGCCCTCCCCCGAGCAGGCCCGCCTCATGGACGCGGCCCTCATCCTC
CACGCCGAGCACGGCTTCAACGCCAGCACCTTCACCGCCATCGCCGCCTTCTCCACGGAG
ACCGACCTCTACTCGGCCATCACCGCCGCCGTGGCCTCCCTGAAGGGGCCGCGCCACGGC
GGGGCCAACGAGGCCGTGATGCGCATGATCCAGGAGATCGGCACCCCCGAGCGGGCCCGG
GAGTGGGTGCGGGAGAAGCTGGCCAAGAAGGAGCGCATCATGGGCATGGGCCACCGGGTC
TACAAGGCCTTTGACCCCAGGGCCGGGGTCCTGGAAAAGCTCGCCCGGTTGGTGGCGGAG
AAGCACGGCCACTCCAAGGAGTACCAGATCCTGAAGATCGTGGAGGAGGAGGCGGGGAAG
GTCCTGAACCCCAGGGGCATCTACCCCAACGTGGACTTCTACTCCGGGGTGGTCTACTCC
GACCTGGGCTTCAGCCTGGAGTTCTTCACCCCCATCTTCGCCGTGGCCCGGATCTCGGGC
TGGGTGGGGCACATCCTGGAGTACCAGGAGCTGGACAACCGCCTCCTCCGCCCCGGGGCC
AAGTACGTGGGGGAGCTGGACGTGCCCTACGTCCCCCTCGAGGCCCGGGAGTAG

# Drug_Target_37_General_Function:
Involved in transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer

# Drug_Target_37_General_References:
Not Available

# Drug_Target_37_HGNC_ID:
Not Available

# Drug_Target_37_HPRD_ID:
Not Available

# Drug_Target_37_ID:
4575

# Drug_Target_37_Locus:
Not Available

# Drug_Target_37_Molecular_Weight:
42323

# Drug_Target_37_Name:
Citrate synthase

# Drug_Target_37_Number_of_Residues:
377

# Drug_Target_37_PDB_ID:
1IXE

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF00285	Citrate_synt

# Drug_Target_37_Protein_Sequence:
>Citrate synthase
MEVARGLEGVLFTESRMCYIDGQQGKLYYYGIPIQELAEKSSFEETTFLLLHGRLPRRQE
LEEFSAALARRRAMPAHLLESFKRYPVSAHPMSFLRTAVSEFGMLDPTEGDISREALYEK
GLDLIAKFATIVAANKRLKEGKEPIPPREDLSHAANFLYMANGVEPSPEQARLMDAALIL
HAEHGFNASTFTAIAAFSTETDLYSAITAAVASLKGPRHGGANEAVMRMIQEIGTPERAR
EWVREKLAKKERIMGMGHRVYKAFDPRAGVLEKLARLVAEKHGHSKEYQILKIVEEEAGK
VLNPRGIYPNVDFYSGVVYSDLGFSLEFFTPIFAVARISGWVGHILEYQELDNRLLRPGA
KYVGELDVPYVPLEARE

# Drug_Target_37_Reaction:
Not Available

# Drug_Target_37_Signals:
None

# Drug_Target_37_Specific_Function:
Not Available

# Drug_Target_37_SwissProt_ID:
Q9LCX9

# Drug_Target_37_SwissProt_Name:
Q9LCX9_THETH

# Drug_Target_37_Synonyms:
Not Available

# Drug_Target_37_Theoretical_pI:
6.60

# Drug_Target_37_Transmembrane_Regions:
None

# Drug_Target_38_Cellular_Location:
Not Available

# Drug_Target_38_Chromosome_Location:
Not Available

# Drug_Target_38_Drug_References:
Not Available

# Drug_Target_38_Essentiality:
Non-Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
U72714

# Drug_Target_38_GenBank_ID_Protein:
Not Available

# Drug_Target_38_GeneCard_ID:
Not Available

# Drug_Target_38_Gene_Name:
aac

# Drug_Target_38_Gene_Sequence:
>546 bp
GTGCACACCCAGGTACACACGGCCCGCCTGGTCCACACCGCCGATCTTGACAGCGAGACC
CGCCAGGACATCCGTCAGATGGTCACCGGCGCGTTTGCCGGTGACTTCACCGAGACCGAC
TGGGAGCACACGCTGGGTGGGATGCACGCCCTGATCTGGCATCACGGGGCGATCATCGCG
CATGCCGCGGTGATCCAGCGGCGACTGATCTACCGCGGCAACGCGCTGCGCTGCGGGTAC
GTCGAAGGCGTTGCGGTGCGGGCGGACTGGCGGGGCCAACGCCTGGTGAGCGCGCTGTTG
GACGCCGTCGAGCAGGTGATGCGCGGCGCTTACCAGCTCGGAGCGCTCAGTTCCTCGGCG
CGGGCCCGCAGACTGTACGCCTCACGCGGCTGGCTGCCCTGGCACGGCCCGACATCGGTA
CTGGCACCAACCGGTCCAGTCCGTACACCCGATGACGACGGAACGGTGTTCGTCCTGCCC
ATCGACATCAGCCTGGACACCTCGGCGGAGCTGATGTGCGATTGGCGCGCGGGCGACGTC
TGGTAA

# Drug_Target_38_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_38_General_References:
12161746	Vetting MW, Hegde SS, Javid-Majd F, Blanchard JS, Roderick SL: Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates. Nat Struct Biol. 2002 Sep;9(9):653-8.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9159528	Ainsa JA, Perez E, Pelicic V, Berthet FX, Gicquel B, Martin C: Aminoglycoside 2'-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2')-Ic gene from Mycobacterium tuberculosis and the aac(2')-Id gene from Mycobacterium smegmatis. Mol Microbiol. 1997 Apr;24(2):431-41.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_38_HGNC_ID:
Not Available

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
4388

# Drug_Target_38_Locus:
Not Available

# Drug_Target_38_Molecular_Weight:
20038

# Drug_Target_38_Name:
Aminoglycoside 2'-N-acetyltransferase

# Drug_Target_38_Number_of_Residues:
181

# Drug_Target_38_PDB_ID:
1M4I

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_38_Protein_Sequence:
>Aminoglycoside 2'-N-acetyltransferase
MHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
HAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSA
RARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDV
W

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Catalyzes the coenzyme A-dependent acetylation of the 2' hydroxyl or amino group of a broad spectrum of aminoglycosides. It confers resistance to aminoglycosides

# Drug_Target_38_SwissProt_ID:
P0A5N0

# Drug_Target_38_SwissProt_Name:
AAC2_MYCTU

# Drug_Target_38_Synonyms:
AAC(2')-Ic
EC 2.3.1.-

# Drug_Target_38_Theoretical_pI:
6.80

# Drug_Target_38_Transmembrane_Regions:
None

# Drug_Target_39_Cellular_Location:
Not Available

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
Not Available

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
Not Available

# Drug_Target_39_GenBank_ID_Gene:
L12710

# Drug_Target_39_GenBank_ID_Protein:
Not Available

# Drug_Target_39_GeneCard_ID:
Not Available

# Drug_Target_39_Gene_Name:
aac(6')-Ii

# Drug_Target_39_Gene_Sequence:
>549 bp
ATGATAATCAGTGAATTTGACCGTAATAATCCAGTATTGAAAGATCAGCTTTCTGATTTA
CTGAGACTGACTTGGCCGGAAGAATATGGAGACAGCTCGGCAGAAGAAGTAGAAGAAATG
ATGAATCCAGAACGAATCGCGGTAGCAGCGGTAGACCAAGATGAGTTAGTAGGATTTATT
GGTGCAATCCCTCAATACGGTATCACAGGTTGGGAATTGCATCCATTAGTTGTAGAAAGC
TCCCGACGAAAGAACCAAATAGGTACTCGATTAGTCAATTACTTAGAAAAAGAAGTAGCT
TCCAGAGGAGGAATCACGATTTATTTAGGTACGGATGATTTAGACCATGGAACAACGTTA
AGTCAAACGGACCTGTATGTGCATACATTTGATAAAGTGGCTTCCATCCAGAACCTTCGT
GAACATCCGTATGAATTCTATGAAAAATTAGGTTATAAAATCGTAGGTGTCTTACCAAAT
GCAAATGGCTGGGACAAACCGGATATTTGGATGGCAAAAACGATTATTCCTCGACCAGAT
TCTCAATAA

# Drug_Target_39_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_39_General_References:
10378269	Wybenga-Groot LE, Draker K, Wright GD, Berghuis AM: Crystal structure of an aminoglycoside 6'-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold. Structure. 1999 May;7(5):497-507.
12592013	Burk DL, Ghuman N, Wybenga-Groot LE, Berghuis AM: X-ray structure of the AAC(6')-Ii antibiotic resistance enzyme at 1.8 A resolution; examination of oligomeric arrangements in GNAT superfamily members. Protein Sci. 2003 Mar;12(3):426-37.
8239603	Costa Y, Galimand M, Leclercq R, Duval J, Courvalin P: Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother. 1993 Sep;37(9):1896-903.

# Drug_Target_39_HGNC_ID:
Not Available

# Drug_Target_39_HPRD_ID:
Not Available

# Drug_Target_39_ID:
4576

# Drug_Target_39_Locus:
Not Available

# Drug_Target_39_Molecular_Weight:
20680

# Drug_Target_39_Name:
Aac(6')-Ii protein

# Drug_Target_39_Number_of_Residues:
182

# Drug_Target_39_PDB_ID:
1B87

# Drug_Target_39_Pathway:
Not Available

# Drug_Target_39_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_39_Protein_Sequence:
>Aac(6')-Ii protein
MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFI
GAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTL
SQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPD
SQ

# Drug_Target_39_Reaction:
Not Available

# Drug_Target_39_Signals:
None

# Drug_Target_39_Specific_Function:
Not Available

# Drug_Target_39_SwissProt_ID:
Q47764

# Drug_Target_39_SwissProt_Name:
Q47764_ENTFC

# Drug_Target_39_Synonyms:
Not Available

# Drug_Target_39_Theoretical_pI:
4.39

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE005674

# Drug_Target_3_GenBank_ID_Protein:
24052809

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
frc

# Drug_Target_3_Gene_Sequence:
>1251 bp
TCAGATGGCGTGGTTTTGCTTCATTGCAGCAATTTCATCGTCGCTATAACCCAGCTCCTG
CAATACAGCAGCGGTATGTTCACCTAATAGCGGCGCAGCTTTAATATCCGGCGTAAAGGC
AGAGAATTTCATTGGACAACCAACGGTCAGATATTTTCCACGCAACGGTTGTTCCACTTC
AACAACACTGCCACTTTGGCGCAAAGAGGGATCAAGTGAAATTTCTTTCATACTTAAAAC
CGGTGCACAAGGAATATCAAACTGAGTCAAATAGGCCACCGCTTCATGTTTATCAATAGT
GACAGTGTATTTTTCGATTTCAGCAAAAATATCGAAAATATGTGGCTGTCGGGCATGGGC
TGTACTGTATGCCGGATCGGTAATCCATTCTGGTTTGCCGATGGCTTTACAGGTGTTTTC
CCAGTTTTGCTCCTGAATAGTGAAATAAATATAGGCGTTAGGATCGGTTTCCCAGCCTTT
ACATTTCAGGATCCAGCCAGGCTGACCGCCACCACCTGCATTACCACCGCGGGGAACTGC
ATCACCAAATGTACCATTCGGATACTGCGGGTATTCTTCCAGATAACCCAATTTATCGAG
ACGCTGCTGGTCACGTAATTTCACGCGGCAAAGGTTCAATACGGCATCCTGCATTGACAT
GGTGACTCGTTGCCCACGCCCCGTTTTTTCGCGATGCAGCAAAGCAGCAAGTAAACCGAT
CAGCAAATGCATTCCGGTGTTGCTGTCACCCAACGCTGCAGCGCTTACCAGCGGCGGACC
ATCCCAAAAACCCGTAGTGGATGCCGCGCCACCCGCTGCCTGAGCAACGTTTTCATAGGC
TTTTACATTCACATAAGGCGAACACTCATCAAACCCTTTGATCGAACCAAAAATCAGACG
TGGATTGATTTCTTGAATATGCTCCCAGGTGAAGCCCATGTGATCAATGGCCCCTGGATG
AAAGTTCTCGACTAAGATATCAGCTTCGCGGATCAGCTTTTCCATTACCTCTTTGCCTTC
CGCTGTTTTGGTATTTAACTCAATAGAACGTTTGTTACTGTTAAGCATGGTGAAGTAAAG
CGCATCGATATCAGGAATATCTCGCAGTTGGTGACGCGTTACGTCACCAACGCCGGGACG
TTCAATTTTAATAACGTCAGCGCCAAACCAGGCCAGCATTTGAGTACAAGATGGGCCAGA
TTGCACACCGGTGAAATCGAGAACTTTAATTCCTTGAAGTGGAGTTGACAT

# Drug_Target_3_General_Function:
Energy production and conversion

# Drug_Target_3_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3457

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
45829

# Drug_Target_3_Name:
Formyl-coenzyme A transferase

# Drug_Target_3_Number_of_Residues:
416

# Drug_Target_3_PDB_ID:
1PT8

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02515	CoA_transf_3

# Drug_Target_3_Protein_Sequence:
>Formyl-coenzyme A transferase
MSTPLQGIKVLDFTGVQSGPSCTQMLAWFGADVIKIERPGVGDVTRHQLRDIPDIDALYF
TMLNSNKRSIELNTKTAEGKEVMEKLIREADILVENFHPGAIDHMGFTWEHIQEINPRLI
FGSIKGFDECSPYVNVKAYENVAQAAGGAASTTGFWDGPPLVSAAALGDSNTGMHLLIGL
LAALLHREKTGRGQRVTMSMQDAVLNLCRVKLRDQQRLDKLGYLEEYPQYPNGTFGDAVP
RGGNAGGGGQPGWILKCKGWETDPNAYIYFTIQEQNWENTCKAIGKPEWITDPAYSTAHA
RQPHIFDIFAEIEKYTVTIDKHEAVAYLTQFDIPCAPVLSMKEISLDPSLRQSGSVVEVE
QPLRGKYLTVGCPMKFSAFTPDIKAAPLLGEHTAAVLQELGYSDDEIAAMKQNHAI

# Drug_Target_3_Reaction:
formyl-CoA + oxalate = formate + oxalyl-CoA

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the transfer of the CoA moiety from formyl-CoA to oxalate

# Drug_Target_3_SwissProt_ID:
P69903

# Drug_Target_3_SwissProt_Name:
FCTA_SHIFL

# Drug_Target_3_Synonyms:
EC 2.8.3.16
Formyl-CoA transferase

# Drug_Target_3_Theoretical_pI:
5.28

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_40_Cellular_Location:
Not Available

# Drug_Target_40_Chromosome_Location:
Not Available

# Drug_Target_40_Drug_References:
Not Available

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
X63158

# Drug_Target_40_GenBank_ID_Protein:
Not Available

# Drug_Target_40_GeneCard_ID:
Not Available

# Drug_Target_40_Gene_Name:
sfp

# Drug_Target_40_Gene_Sequence:
>675 bp
ATGAAGATTTACGGAATTTATATGGACCGCCCGCTTTCACAGGAAGAAAATGAACGGTTC
ATGACTTTCATATCACCTGAAAAACGGGAGAAATGCCGGAGATTTTATCATAAAGAAGAT
GCTCACCGCACCCTGCTGGGAGATGTGCTCGTTCGCTCAGTCATAAGCAGGCAGTATCAG
TTGGACAAATCCGATATCCGCTTTAGCACGCAGGAATACGGGAAGCCGTGCATCCCTGAT
CTTCCCGACGCTCATTTCAACATTTCTCACTCCGGCCGCTGGGTCATTGGTGCGTTTGAT
TCACAGCCGATCGGCATAGATATCGAAAAAACGAAACCGATCAGCCTTGAGATCGCCAAG
CGCTTCTTTTCAAAAACAGAGTACAGCGACCTTTTAGCAAAAGACAAGGACGAGCAGACA
GACTATTTTTATCATCTATGGTCAATGAAAGAAAGCTTTATCAAACAGGAAGGCAAAGGC
TTATCGCTTCCGCTTGATTCCTTTTCAGTGCGCCTGCATCAGGACGGACAAGTATCCATT
GAGCTTCCGGACAGCCATTCCCCATGCTATATCAAAACGTATGAGGTCGATCCCGGCTAC
AAAATGGCTGTATGCGCCGCACACCCTGATTTCCCCGAGGATATCACAATGGTCTCGTAC
GAAGAGCTTTTATAA

# Drug_Target_40_General_Function:
Involved in magnesium ion binding

# Drug_Target_40_General_References:
10581256	Reuter K, Mofid MR, Marahiel MA, Ficner R: Crystal structure of the surfactin synthetase-activating enzyme sfp: a prototype of the 4'-phosphopantetheinyl transferase superfamily. EMBO J. 1999 Dec 1;18(23):6823-31.
1557038	Nakano MM, Corbell N, Besson J, Zuber P: Isolation and characterization of sfp: a gene that functions in the production of the lipopeptide biosurfactant, surfactin, in Bacillus subtilis. Mol Gen Genet. 1992 Mar;232(2):313-21.
8355609	Cosmina P, Rodriguez F, de Ferra F, Grandi G, Perego M, Venema G, van Sinderen D: Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis. Mol Microbiol. 1993 May;8(5):821-31.
8407792	Grossman TH, Tuckman M, Ellestad S, Osburne MS: Isolation and characterization of Bacillus subtilis genes involved in siderophore biosynthesis: relationship between B. subtilis sfpo and Escherichia coli entD genes. J Bacteriol. 1993 Oct;175(19):6203-11.
8639027	Tsuge K, Ano T, Shoda M: Isolation of a gene essential for biosynthesis of the lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8. Arch Microbiol. 1996 Apr;165(4):243-51.
8939709	Lambalot RH, Gehring AM, Flugel RS, Zuber P, LaCelle M, Marahiel MA, Reid R, Khosla C, Walsh CT: A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol. 1996 Nov;3(11):923-36.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9484229	Quadri LE, Weinreb PH, Lei M, Nakano MM, Zuber P, Walsh CT: Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry. 1998 Feb 10;37(6):1585-95.

# Drug_Target_40_HGNC_ID:
Not Available

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
4577

# Drug_Target_40_Locus:
Not Available

# Drug_Target_40_Molecular_Weight:
26136

# Drug_Target_40_Name:
4'-phosphopantetheinyl transferase sfp

# Drug_Target_40_Number_of_Residues:
224

# Drug_Target_40_PDB_ID:
1QR0

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
PF01648	ACPS

# Drug_Target_40_Protein_Sequence:
>4'-phosphopantetheinyl transferase sfp
MKIYGIYMDRPLSQEENERFMTFISPEKREKCRRFYHKEDAHRTLLGDVLVRSVISRQYQ
LDKSDIRFSTQEYGKPCIPDLPDAHFNISHSGRWVIGAFDSQPIGIDIEKTKPISLEIAK
RFFSKTEYSDLLAKDKDEQTDYFYHLWSMKESFIKQEGKGLSLPLDSFSVRLHQDGQVSI
ELPDSHSPCYIKTYEVDPGYKMAVCAAHPDFPEDITMVSYEELL

# Drug_Target_40_Reaction:
Not Available

# Drug_Target_40_Signals:
None

# Drug_Target_40_Specific_Function:
Activates the seven peptidyl carrier protein (PCP) domains of surfactin synthetase SRF1/2/3 by transferring the 4'- phosphopantetheinyl moiety of coenzyme A (CoA) to a serine residue. Required for cells of B.subtilis to become producers of the lipopeptide antibiotics surfactin and plipastatin B1

# Drug_Target_40_SwissProt_ID:
P39135

# Drug_Target_40_SwissProt_Name:
SFP_BACSU

# Drug_Target_40_Synonyms:
EC 2.7.8.-
Surfactin synthetase-activating enzyme

# Drug_Target_40_Theoretical_pI:
5.61

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Not Available

# Drug_Target_41_Chromosome_Location:
Not Available

# Drug_Target_41_Drug_References:
Not Available

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
Not Available

# Drug_Target_41_GenBank_ID_Gene:
AE004091

# Drug_Target_41_GenBank_ID_Protein:
Not Available

# Drug_Target_41_GeneCard_ID:
Not Available

# Drug_Target_41_Gene_Name:
PA3270

# Drug_Target_41_Gene_Sequence:
>588 bp
TCAGCCGGTGAAGCTGGCTTCCAGCGCCGCCTTGACCTGCGGCCATTCGTGGTCGGTGAT
GCTGTAGACGAAGGTGTCGTCTAGCCGCCCGCCGGCCAGCCGCCGGTGGTTGCGCAGCAC
GCCCTCGCGCTGCGCGCCGAGCTTGTCGATGGCGCCCTGGGCGCGCAGGTTGCTCGCCGC
CGTGCTGAGCTGCACGCGGACCATGCGCAGGTTGTCGAAGGCATGCTTGAGCATCAGGTA
CTTGATCATGCGGTTCAGGCCGCTGCCGTGCTGGGCCTGGTCGAGCCAGGTCCAGCCGAT
CTCGCAGGCCGGCAAGGCGGGAAGGAACTCGGCGAAGCGCGTGGTCCCGACCAGTTGCAC
ACCGAGGCGGACGGCGAGCGGCAACGCCCTGCCCTCGCGCTGCTCGGCGAGGCTCTGGCG
GTACCAGTCCGGCCGCGTCGGTCCGTCCATGTACTGCAGCGCCTCGCGGTTGGCTTCGGC
GAGGCTCACCAGCTCGGGAATGTCCGCTTCCACCAGCGGCTCGAGACGCAAGGCTCCGCG
CTGCAGGGTGATCGGTAGCGGCTTGAACATGGGCGCCCTCCTCGACAT

# Drug_Target_41_General_Function:
Involved in N-acetyltransferase activity

# Drug_Target_41_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_41_HGNC_ID:
Not Available

# Drug_Target_41_HPRD_ID:
Not Available

# Drug_Target_41_ID:
4578

# Drug_Target_41_Locus:
Not Available

# Drug_Target_41_Molecular_Weight:
21902

# Drug_Target_41_Name:
Hypothetical protein

# Drug_Target_41_Number_of_Residues:
195

# Drug_Target_41_PDB_ID:
1YRE

# Drug_Target_41_Pathway:
Not Available

# Drug_Target_41_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_41_Protein_Sequence:
>Hypothetical protein
MSRRAPMFKPLPITLQRGALRLEPLVEADIPELVSLAEANREALQYMDGPTRPDWYRQSL
AEQREGRALPLAVRLGVQLVGTTRFAEFLPALPACEIGWTWLDQAQHGSGLNRMIKYLML
KHAFDNLRMVRVQLSTAASNLRAQGAIDKLGAQREGVLRNHRRLAGGRLDDTFVYSITDH
EWPQVKAALEASFTG

# Drug_Target_41_Reaction:
Not Available

# Drug_Target_41_Signals:
None

# Drug_Target_41_Specific_Function:
Not Available

# Drug_Target_41_SwissProt_ID:
Q9HYX1

# Drug_Target_41_SwissProt_Name:
Q9HYX1_PSEAE

# Drug_Target_41_Synonyms:
Not Available

# Drug_Target_41_Theoretical_pI:
9.88

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_42_Chromosome_Location:
Not Available

# Drug_Target_42_Drug_References:
Not Available

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
Not Available

# Drug_Target_42_GenBank_ID_Gene:
L42023

# Drug_Target_42_GenBank_ID_Protein:
Not Available

# Drug_Target_42_GeneCard_ID:
Not Available

# Drug_Target_42_Gene_Name:
cysE

# Drug_Target_42_Gene_Sequence:
>804 bp
ATGACATTAGATGTGTGGCAACATATTCGCCAAGAAGCCAAAGAACTTGCTGAAAACGAA
CCTATGCTTGCTAGTTTTTTTCACTCTACAATTTTAAAGCATCAAAATCTGGGCGGTGCG
CTAAGTTATTTATTGGCTAACAAATTAGCCAATCCTATTATGCCAGCTATTTCTCTCCGT
GAAATTATTGAGGAAGCCTATCAATCTAATCCTTCGATTATTGATTGCGCTGCTTGCGAT
ATCCAAGCTGTCCGCCACCGAGATCCCGCTGTAGAATTGTGGTCCACTCCATTGCTTTAT
TTAAAAGGTTTCCATGCGATTCAAAGTTATCGAATTACCCATTATTTATGGAATCAAAAT
CGTAAATCCCTTGCCCTTTATTTACAAAACCAAATTTCAGTAGCTTTCGATGTAGATATT
CACCCAGCGGCGAAAATTGGCCACGGAATTATGTTCGACCATGCAACAGGTATTGTTGTG
GGTGAAACATCTGTAATCGAAAATGATGTTTCAATTTTGCAAGGGGTAACGCTTGGCGGT
ACGGGAAAAGAATCAGGCGATCGTCATCCCAAAGTACGCGAGGGTGTTATGATTGGGGCG
GGTGCAAAAATTCTCGGTAATATTGAAGTAGGTAAATACGCCAAAATTGGGGCAAACTCT
GTTGTGCTTAACCCTGTGCCGGAATATGCCACAGCGGCTGGCGTGCCTGCTCGTATTGTG
AGTCAAGATAAAGCAGCAAAACCTGCTTTCGATATGAACCAATATTTTATCGGCATTGAT
GATGGAATGAATTTAAATATATAA

# Drug_Target_42_General_Function:
Involved in serine O-acetyltransferase activity

# Drug_Target_42_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_42_HGNC_ID:
Not Available

# Drug_Target_42_HPRD_ID:
Not Available

# Drug_Target_42_ID:
4579

# Drug_Target_42_Locus:
Not Available

# Drug_Target_42_Molecular_Weight:
29167

# Drug_Target_42_Name:
Serine acetyltransferase

# Drug_Target_42_Number_of_Residues:
267

# Drug_Target_42_PDB_ID:
1SST

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF00132	Hexapep
PF06426	SATase_N

# Drug_Target_42_Protein_Sequence:
>Serine acetyltransferase
MTLDVWQHIRQEAKELAENEPMLASFFHSTILKHQNLGGALSYLLANKLANPIMPAISLR
EIIEEAYQSNPSIIDCAACDIQAVRHRDPAVELWSTPLLYLKGFHAIQSYRITHYLWNQN
RKSLALYLQNQISVAFDVDIHPAAKIGHGIMFDHATGIVVGETSVIENDVSILQGVTLGG
TGKESGDRHPKVREGVMIGAGAKILGNIEVGKYAKIGANSVVLNPVPEYATAAGVPARIV
SQDKAAKPAFDMNQYFIGIDDGMNLNI

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
None

# Drug_Target_42_Specific_Function:
Acetyl-CoA + L-serine = CoA + O-acetyl-L- serine

# Drug_Target_42_SwissProt_ID:
P43886

# Drug_Target_42_SwissProt_Name:
CYSE_HAEIN

# Drug_Target_42_Synonyms:
EC 2.3.1.30
SAT

# Drug_Target_42_Theoretical_pI:
6.51

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Not Available

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
Not Available

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
Not Available

# Drug_Target_43_GenBank_ID_Gene:
U85944

# Drug_Target_43_GenBank_ID_Protein:
Not Available

# Drug_Target_43_GeneCard_ID:
Not Available

# Drug_Target_43_Gene_Name:
gltA

# Drug_Target_43_Gene_Sequence:
>1140 bp
ATGACCGAACCAACAATTCATAAGGGCCTTGCCGGCGTCACGGCGGATGTCACCGCCATT
TCGAAGGTCAATTCTGATACCAACTCGCTGCTGTACCGTGGATACCCCGTTCAGGAACTG
GCTGCTAAGTGCAGCTTTGAACAGGTGGCCTACTTGCTGTGGAACAGCGAACTGCCCAAC
GATTCCGAGCTGAAAGCTTTCGTAAATTTCGAACGCTCCCACCGGAAACTGGATGAGAAC
GTCAAAGGGGCAATAGACCTCCTCTCCACTGCCTGTCACCCTATGGACGTTGCGCGGACC
GCCGTCTCAGTTCTGGGAGCCAACCACGCCAGGGCGCAGGATTCCTCCCCGGAAGCAAAT
CTAGAAAAGGCGATGTCGCTGCTGGCAACCTTCCCGTCCGTCGTCGCCTACGACCAAAGG
CGACGACGCGGTGAGGAACTTATCGAACCACGAGAGGATCTCGATTACTCCGCGAACTTC
CTGTGGATGACTTTTGGCGAAGAGGCAGCGCCGGAGGTTGTGGAAGCCTTCAACGTCTCC
ATGATTCTCTACGCGGAGCATTCCTTCAACGCCTCGACGTTCACGGCCCGGGTCATCACC
TCCACCCTGGCGGATCTGCATTCGGCGGTGACCGGAGCCATAGGTGCCCTCAAGGGGCCG
CTGCACGGGGGTGCCAACGAGGCCGTGATGCATACCTTTGAGGAGATTGGGATCCGCAAG
GACGAATCCCTCGATGAGGCAGCCACGCGTTCGAAAGCTTGGATGGTCGATGCCCTTGCG
CAGAAGAAAAAGGTCATGGGTTTTGGGCACCGCGTGTACAAGAATGGTGACTCCCGGGTC
CCCACCATGAAGAGCGCTCTGGACGCCATGATCAAACATTATGATCGTCCGGAAATGCTC
GGCCTGTACAACGGACTCGAAGCCGCTATGGAAGAGGCCAAGCAGATCAAGCCGAATCTC
GACTACCCGGCAGGACCCACCTATAACCTGATGGGCTTTGACACGGAGATGTTCACTCCG
CTCTTCATCGCCGCGCGCATCACCGGTTGGACCGCCCATATCATGGAACAAGTGGCGGAC
AACGCTCTGATCCGCCCACTCAGCGAATATAACGGTCCTGAGCAGCGCCAGGTCCCCTGA

# Drug_Target_43_General_Function:
Involved in transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer

# Drug_Target_43_General_References:
9310359	Gerike U, Danson MJ, Russell NJ, Hough DW: Sequencing and expression of the gene encoding a cold-active citrate synthase from an Antarctic bacterium, strain DS2-3R. Eur J Biochem. 1997 Aug 15;248(1):49-57.
9551556	Russell RJ, Gerike U, Danson MJ, Hough DW, Taylor GL: Structural adaptations of the cold-active citrate synthase from an Antarctic bacterium. Structure. 1998 Mar 15;6(3):351-61.

# Drug_Target_43_HGNC_ID:
Not Available

# Drug_Target_43_HPRD_ID:
Not Available

# Drug_Target_43_ID:
4580

# Drug_Target_43_Locus:
Not Available

# Drug_Target_43_Molecular_Weight:
41833

# Drug_Target_43_Name:
Citrate synthase

# Drug_Target_43_Number_of_Residues:
379

# Drug_Target_43_PDB_ID:
1A59

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
PF00285	Citrate_synt

# Drug_Target_43_Protein_Sequence:
>Citrate synthase
MTEPTIHKGLAGVTADVTAISKVNSDTNSLLYRGYPVQELAAKCSFEQVAYLLWNSELPN
DSELKAFVNFERSHRKLDENVKGAIDLLSTACHPMDVARTAVSVLGANHARAQDSSPEAN
LEKAMSLLATFPSVVAYDQRRRRGEELIEPREDLDYSANFLWMTFGEEAAPEVVEAFNVS
MILYAEHSFNASTFTARVITSTLADLHSAVTGAIGALKGPLHGGANEAVMHTFEEIGIRK
DESLDEAATRSKAWMVDALAQKKKVMGFGHRVYKNGDSRVPTMKSALDAMIKHYDRPEML
GLYNGLEAAMEEAKQIKPNLDYPAGPTYNLMGFDTEMFTPLFIAARITGWTAHIMEQVAD
NALIRPLSEYNGPEQRQVP

# Drug_Target_43_Reaction:
Not Available

# Drug_Target_43_Signals:
None

# Drug_Target_43_Specific_Function:
Acetyl-CoA + H(2)O + oxaloacetate = citrate + CoA

# Drug_Target_43_SwissProt_ID:
O34002

# Drug_Target_43_SwissProt_Name:
CISY_ABDS2

# Drug_Target_43_Synonyms:
EC 2.3.3.1

# Drug_Target_43_Theoretical_pI:
5.17

# Drug_Target_43_Transmembrane_Regions:
None

# Drug_Target_44_Cellular_Location:
Not Available

# Drug_Target_44_Chromosome_Location:
Not Available

# Drug_Target_44_Drug_References:
Not Available

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
Not Available

# Drug_Target_44_GenBank_ID_Gene:
M93187

# Drug_Target_44_GenBank_ID_Protein:
Not Available

# Drug_Target_44_GeneCard_ID:
Not Available

# Drug_Target_44_Gene_Name:
fcbC

# Drug_Target_44_Gene_Sequence:
>456 bp
ATGCATCGTACTTCGAACGGCTCTCACGCAACGGGTGGAAACCTTCCAGATGTCGCCAGT
CACTATCCCGTCGCCTACGAGCAGACCCTTGATGGAACCGTTGGATTCGTCATCGACGAG
ATGACACCTGAACGAGCGACAGCATCCGTAGAAGTTACAGACACCCTACGCCAGCGCTGG
GGGCTGGTCCATGGAGGCGCCTACTGCGCGTTGGCGGAGATGCTGGCCACGGAGGCAACG
GTCGCGGTAGTGCACGAGAAGGGCATGATGGCCGTCGGGCAGTCTAACCACACCTCGTTT
TTTCGGCCCGTGAAGGAGGGACATGTGAGAGCCGAGGCCGTCCGCATCCATGCGGGGTCA
ACCACATGGTTCTGGGACGTCTCATTGAGAGACGACGCCGGCAGGTTATGTGCGGTTAGC
AGCATGTCCATTGCTGTCCGTCCGCGCCGAGACTAG

# Drug_Target_44_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_44_General_References:
1476446	Schmitz A, Gartemann KH, Fiedler J, Grund E, Eichenlaub R: Cloning and sequence analysis of genes for dehalogenation of 4-chlorobenzoate from Arthrobacter sp. strain SU. Appl Environ Microbiol. 1992 Dec;58(12):4068-71.

# Drug_Target_44_HGNC_ID:
Not Available

# Drug_Target_44_HPRD_ID:
Not Available

# Drug_Target_44_ID:
4404

# Drug_Target_44_Locus:
Not Available

# Drug_Target_44_Molecular_Weight:
16395

# Drug_Target_44_Name:
FcbC1 protein

# Drug_Target_44_Number_of_Residues:
151

# Drug_Target_44_PDB_ID:
1Q4U

# Drug_Target_44_Pathway:
Not Available

# Drug_Target_44_Pfam_Domain_Function:
PF03061	4HBT

# Drug_Target_44_Protein_Sequence:
>FcbC1 protein
MHRTSNGSHATGGNLPDVASHYPVAYEQTLDGTVGFVIDEMTPERATASVEVTDTLRQRW
GLVHGGAYCALAEMLATEATVAVVHEKGMMAVGQSNHTSFFRPVKEGHVRAEAVRIHAGS
TTWFWDVSLRDDAGRLCAVSSMSIAVRPRRD

# Drug_Target_44_Reaction:
Not Available

# Drug_Target_44_Signals:
None

# Drug_Target_44_Specific_Function:
Not Available

# Drug_Target_44_SwissProt_ID:
Q04416

# Drug_Target_44_SwissProt_Name:
4HBT_ARTSP

# Drug_Target_44_Synonyms:
Not Available

# Drug_Target_44_Theoretical_pI:
6.72

# Drug_Target_44_Transmembrane_Regions:
None

# Drug_Target_45_Cellular_Location:
Cytoplasm

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
Not Available

# Drug_Target_45_GenBank_ID_Gene:
X01631

# Drug_Target_45_GenBank_ID_Protein:
Not Available

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
glmU

# Drug_Target_45_Gene_Sequence:
Not Available

# Drug_Target_45_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_45_General_References:
6395859	Walker JE, Gay NJ, Saraste M, Eberle AN: DNA sequence around the Escherichia coli unc operon. Completion of the sequence of a 17 kilobase segment containing asnA, oriC, unc, glmS and phoS. Biochem J. 1984 Dec 15;224(3):799-815.
7686882	Burland V, Plunkett G 3rd, Daniels DL, Blattner FR: DNA sequence and analysis of 136 kilobases of the Escherichia coli genome: organizational symmetry around the origin of replication. Genomics. 1993 Jun;16(3):551-61.
8083170	Mengin-Lecreulx D, van Heijenoort J: Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis. J Bacteriol. 1994 Sep;176(18):5788-95.
8407787	Mengin-Lecreulx D, van Heijenoort J: Identification of the glmU gene encoding N-acetylglucosamine-1-phosphate uridyltransferase in Escherichia coli. J Bacteriol. 1993 Oct;175(19):6150-7.
8555230	Gehring AM, Lees WJ, Mindiola DJ, Walsh CT, Brown ED: Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli. Biochemistry. 1996 Jan 16;35(2):579-85.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_45_HGNC_ID:
Not Available

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
3697

# Drug_Target_45_Locus:
Not Available

# Drug_Target_45_Molecular_Weight:
49191

# Drug_Target_45_Name:
Bifunctional protein glmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase

# Drug_Target_45_Number_of_Residues:
456

# Drug_Target_45_PDB_ID:
1HV9

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
PF00132	Hexapep
PF01128	IspD

# Drug_Target_45_Protein_Sequence:
>Bifunctional protein glmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase
MLNNAMSVVILAAGKGTRMYSDLPKVLHTLAGKAMVQHVIDAANELGAAHVHLVYGHGGD
LLKQALKDDNLNWVLQAEQLGTGHAMQQAAPFFADDEDILMLYGDVPLISVETLQRLRDA
KPQGGIGLLTVKLDDPTGYGRITRENGKVTGIVEHKDATDEQRQIQEINTGILIANGADM
KRWLAKLTNNNAQGEYYITDIIALAYQEGREIVAVHPQRLSEVEGVNNRLQLSRLERVYQ
SEQAEKLLLAGVMLRDPARFDLRGTLTHGRDVEIDTNVIIEGNVTLGHRVKIGTGCVIKN
SVIGDDCEISPYTVVEDANLAAACTIGPFARLRPGAELLEGAHVGNFVEMKKARLGKGSK
AGHLTYLGDAEIGDNVNIGAGTITCNYDGANKFKTIIGDDVFVGSDTQLVAPVTVGKGAT
IAAGTTVTRNVGENALAISRVPQTQKEGWRRPVKKK

# Drug_Target_45_Reaction:
UTP + N-acetyl-alpha-D-glucosamine 1-phosphate = diphosphate + UDP-N-acetyl-D-glucosamine

# Drug_Target_45_Signals:
None

# Drug_Target_45_Specific_Function:
Catalyzes the last two sequential reactions in the de novo biosynthetic pathway for UDP-GlcNAc. Responsible for the acetylation of Glc-N-1-P to give GlcNAc-1-P and for the uridyl transfer from UTP to GlcNAc-1-P which produces UDP-GlcNAc

# Drug_Target_45_SwissProt_ID:
P0ACC7

# Drug_Target_45_SwissProt_Name:
GLMU_ECOLI

# Drug_Target_45_Synonyms:
EC 2.3.1.157]
EC 2.7.7.23
Glucosamine-1-phosphate N-acetyltransferase
N-acetylglucosamine-1-phosphate uridyltransferase

# Drug_Target_45_Theoretical_pI:
6.52

# Drug_Target_45_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Endoplasmic reticulum (Potential). Peroxisome (Potential). Mitochondrion
mitochondrial inner membra

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
CRAT

# Drug_Target_4_GenBank_ID_Gene:
X78706

# Drug_Target_4_GenBank_ID_Protein:
927415

# Drug_Target_4_GeneCard_ID:
CRAT

# Drug_Target_4_Gene_Name:
CRAT

# Drug_Target_4_Gene_Sequence:
>1876 bp
AGCCTTCGCTGCCAGGACCGTGGTGAAGCCTCTGGGCTTCCTGAAGCCCTTCTCCTTGAT
GAAGGCTTCCAGCCGCTTCAAGGCACACCAGGATGCCCTGCCACGGCTGCCCGTGCCCCC
TCTCCAGCAGTCCCTGGACCACTACCTGAAGGCGCTGCAGCCCATCGTGAGTGAGGAGGA
GTGGGCCCACACCAAGCAGCTGGTGGATGAGTTTCAGGCCTCAGGAGGTGTAGGGGAGCG
CCTGCAGAAGGGGCTGGGGCGTCGGGCCAGGAAGACGGAGAACTGGCTGTCTGAGTGGTG
GCTCAAGACCGCCTACCTCCAGTACCGCCAGCCTGTGGTCATCTACTCGAGCCCAGGCGT
GATGCTACCCAAGCAGGACTTCGTGGACCTGCAGGGTCAGCTCCGATTTGCTGCCAAACT
CATTGAGGGTGTGTTGGATTTCAAGGTCATGATTGACAACGAGACCCTGCCCGTGGAGTA
CCTGGNGGGGAAGCCACTGTGCATGAACCAGTACTATCAGATCTTGTCCTCCTGCCGAGT
GCCGGGCCCCAAGCAGGACACAGTCAGCAACTTCAGCAAGACCAAGAAGCCTCCCACGCA
CATCACCGTGGTACACAACTACCAGTTTTTTGAGCTGGATGTGTACCACAGTGACGGGAC
ACCCCTCACTGCGGATCAGATCTTTGTGCAGCTGGAGAAGATCTGGAACTCATCCCTACA
GACCAACAAGGAGCCTGTGGGCATCCTCACCTCCAACCACCGCAACTCCTGGGCCAAGGC
ATACAACACCCTCATCAAAGACAAGGTGAACCGGGATTCCGTGCGCTCCATCCAGAAGAG
CATCTTCACCGTGTGCCTAGATGCAACCATGCCCAGGGTCTCAGAAGACGTGTACCGCAG
CCACGTGGCAGGCCAGATGCTGCATGGGGGCGGCAGCAGGCTCAACAGCGGCAACCGCTG
GTTTGACAAGACGCTGCAGTTCATCGTGGCAGAAGATGGCTCCTGTGGGCTTGTGTACGA
GCATGCTGCAGCNGAGGGTTTCCCTATTGTCACCCTTCTGGACTATGTCATCGAGTACAC
GAAGAAACCCGAGCTTGTGCNGTCTCCCATGGTGCCCCTGCCCATGCCCAAGAAGCTGCG
GTTCAACATCACCCCCGAGATCAAGAGCGACATCGAGAAGGCCAAGCAGAACCTCAGCAT
CATGATCCANNACCTGGATATCACCGTGATGGTGTTCCACCATTTTGGAAAAGACTTCCC
CAAGTCGGAGAAGCTAAGCCCAGATGCCTTCATCCAGATGGCTTTGCAGCTGGCCTACTA
CAGGATCTACGGACAGGCATGTGCCACCTATGAAAGTNCNTCCCTGCGCATGTTTCACCT
GGGCCGCACCGACACCATCCGCTCGGCTTCCATGGACTCACTCACCTTTGTCAAGGCCAT
GGATGACTCCAGCGTCACGGAGCACCAGAAGGTGGAGCTGCTGCGGAAGGCCGTGCAGGC
CCACCGGGGCTACACCGACCGGGCCATCCGCGGGGAGGCCTTTGGTCGACACCTGCTGGG
CCTGAAGCTGCAGGCCATCGAGGACCTGGTGAGCACGCCCGACATCTTCATGGACACCTC
CTACGCCATCGCCATGCACTTCCACCTCTCCACCAGCCAGGTCCCTGCCAAGACAGACTG
TGTCATGTTCTTCGGGCCCGTGGTCCCCGACGGCTACGGTGTCTGCTATAACCCCATGGA
GGCCCACATCAACTTCTCCCTGTCGGCCTACAACAGCTGCGCGGAGACCAACGCCGCCCG
CCTGGCGCATTACCTGGAGAAGGCGCTCCTGGACATGCGTGCCCTGCTGCAGAGCCACCC
CCGGGCCAAGCTCTGA

# Drug_Target_4_General_Function:
Involved in acyltransferase activity

# Drug_Target_4_General_References:
7829107	Corti O, Finocchiaro G, Rossi E, Zuffardi O, DiDonato S: Molecular cloning of cDNAs encoding human carnitine acetyltransferase and mapping of the corresponding gene to chromosome 9q34.1. Genomics. 1994 Sep 1;23(1):94-9.
7945262	Corti O, DiDonato S, Finocchiaro G: Divergent sequences in the 5' region of cDNA suggest alternative splicing as a mechanism for the generation of carnitine acetyltransferases with different subcellular localizations. Biochem J. 1994 Oct 1;303 ( Pt 1):37-41.

# Drug_Target_4_HGNC_ID:
HGNC:2342

# Drug_Target_4_HPRD_ID:
08971

# Drug_Target_4_ID:
551

# Drug_Target_4_Locus:
9q34.1

# Drug_Target_4_Molecular_Weight:
70927

# Drug_Target_4_Name:
Carnitine O-acetyltransferase

# Drug_Target_4_Number_of_Residues:
626

# Drug_Target_4_PDB_ID:
1S5O

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00755	Carn_acyltransf

# Drug_Target_4_Protein_Sequence:
>Carnitine O-acetyltransferase
MLAFAARTVVKPLGFLKPFSLMKASSRFKAHQDALPRLPVPPLQQSLDHYLKALQPIVSE
EEWAHTKQLVDEFQASGGVGERLQKGLERRARKTENWLSEWWLKTAYLQYRQPVVIYSSP
GVMLPKQDFVDLQGQLRFAAKLIEGVLDFKVMIDNETLPVEYLGGKPLCMNQYYQILSSC
RVPGPKQDTVSNFSKTKKPPTHITVVHNYQFFELDVYHSDGTPLTADQIFVQLEKIWNSS
LQTNKEPVGILTSNHRNSWAKAYNTLIKDKVNRDSVRSIQKSIFTVCLDATMPRVSEDVY
RSHVAGQMLHGGGSRLNSGNRWFDKTLQFIVAEDGSCGLVYEHAAAEGFPIVTLLDYVIE
YTKKPELVRSPMVPLPMPKKLRFNITPEIKSDIEKAKQNLSIMIQDLDITVMVFHHFGKD
FPKSEKLSPDAFIQMALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASMDSLTFVK
AMDDSSVTEHQKVELLRKAVQAHRGYTDRAIRGEAFDRHLLGLKLQAIEDLVSMPDIFMD
TSYAIAMHFHLSTSQVPAKTDCVMFFGPVVPDGYGVCYNPMEAHINFSLSAYNSCAETNA
ARLAHYLEKALLDMRALLQSHPRAKL

# Drug_Target_4_Reaction:
acetyl-CoA + carnitine = CoA + O-acetylcarnitine

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria

# Drug_Target_4_SwissProt_ID:
P43155

# Drug_Target_4_SwissProt_Name:
CACP_HUMAN

# Drug_Target_4_Synonyms:
CAT
Carnitine acetylase
Carnitine acetyltransferase
CrAT
EC 2.3.1.7

# Drug_Target_4_Theoretical_pI:
8.63

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasm

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
X67748

# Drug_Target_5_GenBank_ID_Protein:
495242

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
caiB

# Drug_Target_5_Gene_Sequence:
>1218 bp
ATGGATCATCTACCCATGCCGAAATTCGGACCGCTGGCCGGATTGCGCGTTGTCTTCTCC
GGTATCGAAATCGCCGGACCGTTTGCCGGGCAAATGTTCGCAGAATGGGGTGCGGAAGTT
ATCTGGATCGAGAACGTCGCCTGGGCCGACACCATTCGCGTTCAACCGAACTACCCGCAG
CTCTCCCGCCGCAATTTGCACGCGCTGTCGTTAAATATTTTCAAAGATGAAGGCCGCGAA
GCGTTTCTGAAATTAATGGAAACCACCGATATCTTCATCGAAGCCAGTAAAGGTCCGGCC
TTTGCCCGTCGTGGCATTACCGATGAAGTACTGTGGCAGCACAACCCGAAACTGGTTATC
GCTCACCTGTCCGGTTTTGGTCAGTACGGCACCGAGGAGTACACCAATCTTCCGGCCTAT
AACACCATCGCCCAGGCCTTCAGTGGTTACCTGATTCAGAACGGTGATGTTGACCAGCCA
ATGCCTGCCTTCCCGTATACCGCCGATTACTTTTCTGGCCTGACCGCCACCACGGCGGCG
CTGGCAGCACTGCATAAAGCGCGTGAAACCGGTAAAGGCGAAAGTATCGACATCGCCATG
TATGAAGTGATGCTGCGTATGGGCCAGTACTTCATGATGGATTACTTCAACGGCGGCGAA
ATGTGCCCGCGCATGAGCAAAGGTAAAGATCCCTACTACGCCGGCTGCGGTCTGTATAAA
TGTGCCGACGGCTACATCGTGATGGAACTGGTGGGTATTACCCAAATTGAAGAGTGCTTT
AAAGATATTGGCCTCGCACATCTACTCGGTACGCCGGAAATCCCGGAAGGCACTCAGCTT
ATCCACCGTATCGAATGCCCTTACGGCCCACTGGTAGAAGAAAAACTCGATGCCTGGCTG
GCGGCACATACCATCGCAGAAGTTAAAGAACGCTTTGCCGAACTGAATATCGCCTGTGCC
AAAGTACTGACCGTACCGGAACTGGAAAGCAATCCACAGTATGTTGCCCGTGAATCAATC
ACTCAGTGGCAAACGATGGATGGTCGCACCTGCAAAGGGCCGAACATCATGCCGAAATTC
AAAAATAACCCCGGACAAATCTGGCGCGGAATGCCCTCACATGGCATGGACACGGCTGCC
ATTTTGAAAAATATCGGCTACAGCGAAAACGACATTCAGGAGTTGGTCAGCAAAGGTCTG
GCCAAAGTTGAGGACTAA

# Drug_Target_5_General_Function:
Energy production and conversion

# Drug_Target_5_General_References:
10339822	Elssner T, Preusser A, Wagner U, Kleber HP: Metabolism of L(-)-carnitine by Enterobacteriaceae under aerobic conditions. FEMS Microbiol Lett. 1999 May 15;174(2):295-301.
11551212	Elssner T, Engemann C, Baumgart K, Kleber HP: Involvement of coenzyme A esters and two new enzymes, an enoyl-CoA hydratase and a CoA-transferase, in the hydration of crotonobetaine to L-carnitine by Escherichia coli. Biochemistry. 2001 Sep 18;40(37):11140-8.
1630901	Yura T, Mori H, Nagai H, Nagata T, Ishihama A, Fujita N, Isono K, Mizobuchi K, Nakata A: Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res. 1992 Jul 11;20(13):3305-8.
7815937	Eichler K, Bourgis F, Buchet A, Kleber HP, Mandrand-Berthelot MA: Molecular characterization of the cai operon necessary for carnitine metabolism in Escherichia coli. Mol Microbiol. 1994 Sep;13(5):775-86.
8188598	Eichler K, Schunck WH, Kleber HP, Mandrand-Berthelot MA: Cloning, nucleotide sequence, and expression of the Escherichia coli gene encoding carnitine dehydratase. J Bacteriol. 1994 May;176(10):2970-5.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
3024

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
45127

# Drug_Target_5_Name:
Crotonobetainyl-CoA:carnitine CoA-transferase

# Drug_Target_5_Number_of_Residues:
405

# Drug_Target_5_PDB_ID:
1XVV

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02515	CoA_transf_3

# Drug_Target_5_Protein_Sequence:
>Crotonobetainyl-CoA:carnitine CoA-transferase
MDHLPMPKFGPLAGLRVVFSGIEIAGPFAGQMFAEWGAEVIWIENVAWADTIRVQPNYPQ
LSRRNLHALSLNIFKDEGREAFLKLMETTDIFIEASKGPAFARRGITDEVLWQHNPKLVI
AHLSGFGQYGTEEYTNLPAYNTIAQAFSGYLIQNGDVDQPMPAFPYTADYFSGLTATTAA
LAALHKVRETGKGESIDIAMYEVMLRMGQYFMMDYFNGGEMCPRMSKGKDPYYAGCGLYK
CADGYIVMELVGITQIEECFKDIGLAHLLGTPEIPEGTQLIHRIECPYGPLVEEKLDAWL
ATHTIAEVKERFAELNIACAKVLTVPELESNPQYVARESITQWQTMDGRTCKGPNIMPKF
KNNPGQIWRGMPSHGMDTAAILKNIGYSENDIQELVSKGLAKVED

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Catalyzes the reversible transfer of the CoA moiety from gamma-butyrobetainyl-CoA to L-carnitine to generate L-carnitinyl- CoA and gamma-butyrobetaine. Is also able to catalyze the reversible transfer of the CoA moiety from gamma-butyrobetainyl- CoA or L-carnitinyl-CoA to crotonobetaine to generate crotonobetainyl-CoA

# Drug_Target_5_SwissProt_ID:
P31572

# Drug_Target_5_SwissProt_Name:
CAIB_ECOLI

# Drug_Target_5_Synonyms:
EC 2.8.3.-

# Drug_Target_5_Theoretical_pI:
4.89

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X08035

# Drug_Target_6_GenBank_ID_Protein:
42370

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
pflB

# Drug_Target_6_Gene_Sequence:
>2283 bp
ATGTCCGAGCTTAATGAAAAGTTAGCCACAGCCTGGGAAGGTTTTACCAAAGGTGACTGG
CAGAATGAAGTAAACGTCCGTGACTTCATTCAGAAAAACTACACTCCGTACGAGGGTGAC
GAGTCCTTCCTGGCTGGCGCTACTGAAGCGACCACCACCCTGTGGGACAAAGTAATGGAA
GGCGTTAAACTGGAAAACCGCACTCACGCGCCAGTTGACTTTGACACCGCTGTTGCTTCC
ACCATCACCTCTCACGACGCTGGCTACATCAACAAGCAGCTTGAGAAAATCGTTGGTCTG
CAGACTGAAGCTCCGCTGAAACGTGCTCTTATCCCGTTCGGTGGTATCAAAATGATCGAA
GGTTCCTGCAAAGCGTACAACCGCGAACTGGATCCGATGATCAAAAAAATCTTCACTGAA
TACCGTAAAACTCACAACCAGGGCGTGTTCGACGTTTACACTCCGGACATCCTGCGTTGC
CGTAAATCTGGTGTTCTGACCGGTCTGCCAGATGCATATGGCCGTGGCCGTATCATCGGT
GACTACCGTCGCGTTGCGCTGTACGGTATCGACTACCTGATGAAAGACAAACTGGCACAG
TTCACTTCTCTGCAGGCTGATCTGGAAAACGGCGTAAACCTGGAACAGACTATCCGTCTG
CGCGAAGAAATCGCTGAACAGCACCGCGCTCTGGGTCAGATGAAAGAAATGGCTGCGAAA
TACGGCTACGACATCTCTGGTCCGGCTACCAACGCTCAGGAAGCTATCCAGTGGACTTAC
TTCGGCTACCTGGCTGCTGTTAAGTCTCAGAACGGTGCTGCAATGTCCTTCGGTCGTACC
TCCACCTTCCTGGATGTGTACATCGAACGTGACCTGAAAGCTGGCAAGATCACCGAACAA
GAAGCGCAGGAAATGGTTGACCACCTGGTCATGAAACTGCGTATGGTTCGCTTCCTGCGT
ACTCCGGAATACGATGAACTGTTCTCTGGCGACCCGATCTGGGCAACCGAATCTATCGGT
GGTATGGGCCTCGACGGTCGTACCCTGGTTACCAAAAACAGCTTCCGTTTCCTGAACACC
CTGTACACCATGGGTCCGTCTCCGGAACCGAACATGACCATTCTGTGGTCTGAAAAACTG
CCGCTGAACTTCAAGAAATTCGCCGCTAAAGTGTCCATCGACACCTCTTCTCTGCAGTAT
GAGAACGATGACCTGATGCGTCCGGACTTCAACAACGATGACTACGCTATTGCTTGCTGC
GTAAGCCCGATGATCGTTGGTAAACAAATGCAGTTCTTCGGTGCGCGTGCAAACCTGGCG
AAAACCATGCTGTACGCAATCAACGGCGGCGTTGACGAAAAACTGAAAATGCAGGTTGGT
CCGAAGTCTGAACCGATCAAAGGCGATGTCCTGAACTATGATGAAGTGATGGAGCGCATG
GATCACTTCATGGACTGGCTGGCTAAACAGTACATCACTGCACTGAACATCATCCACTAC
ATGCACGACAAGTACAGCTACGAAGCCTCTCTGATGGCGCTGCACGACCGTGACGTTATC
CGCACCATGGCGTGTGGTATCGCTGGTCTGTCCGTTGCTGCTGACTCCCTGTCTGCAATC
AAATATGCGAAAGTTAAACCGATTCGTGACGAAGACGGTCTGGCTATCGACTTCGAAATC
GAAGGCGAATACCCGCAGTTTGGTAACAATGATCCGCGTGTAGATGACCTGGCTGTTGAC
CTGGTAGAACGTTTCATGAAGAAAATTCAGAAACTGCACACCTACCGTGACGCTATCCCG
ACTCAGTCTGTTCTGACCATCACTTCTAACGTTGTGTATGGTAAGAAAACGGGTAACACC
CCAGACGGTCGTCGTGCTGGCGCGCCGTTCGGACCGGGTGCTAACCCGATGCACGGTCGT
GACCAGAAAGGTGCAGTAGCCTCTCTGACTTCCGTTGCTAAACTGCCGTTTGCTTACGCT
AAAGATGGTATCTCCTACACCTTCTCTATCGTTCCGAACGCACTGGGTAAAGACGACGAA
GTTCGTAAGACCAACCTGGCTGGTCTGATGGATGGTTACTTCCACCACGAAGCATCCATC
GAAGGTGGTCAGCACCTGAACGTTAACGTGATGAACCGTGAAATGCTGCTCGACGCGATG
GAAAACCCGGAAAAATATCCGCAGCTGACCATCCGTGTATCTGGCTACGCAGTACGTTTC
AACTCGCTGACTAAAGAACAGCAGCAGGACGTTATTACTCGTACCTTCACTCAATCTATG
TAA

# Drug_Target_6_General_Function:
Energy production and conversion

# Drug_Target_6_General_References:
10504733	Becker A, Fritz-Wolf K, Kabsch W, Knappe J, Schultz S, Volker Wagner AF: Structure and mechanism of the glycyl radical enzyme pyruvate formate-lyase. Nat Struct Biol. 1999 Oct;6(10):969-75.
1310545	Wagner AF, Frey M, Neugebauer FA, Schafer W, Knappe J: The free radical in pyruvate formate-lyase is located on glycine-734. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):996-1000.
2651404	Sawers G, Bock A: Novel transcriptional control of the pyruvate formate-lyase gene: upstream regulatory sequences and multiple promoters regulate anaerobic expression. J Bacteriol. 1989 May;171(5):2485-98.
3053170	Rodel W, Plaga W, Frank R, Knappe J: Primary structures of Escherichia coli pyruvate formate-lyase and pyruvate-formate-lyase-activating enzyme deduced from the DNA nucleotide sequences. Eur J Biochem. 1988 Oct 15;177(1):153-8.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9629924	Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998 May;19(5):837-44.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
3178

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
85358

# Drug_Target_6_Name:
Formate acetyltransferase 1

# Drug_Target_6_Number_of_Residues:
760

# Drug_Target_6_PDB_ID:
1MZO

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01228	Gly_radical
PF02901	PFL

# Drug_Target_6_Protein_Sequence:
>Formate acetyltransferase 1
MSELNEKLATAWEGFTKGDWQNEVNVRDFIQKNYTPYEGDESFLAGATEATTTLWDKVME
GVKLENRTHAPVDFDTAVASTITSHDAGYINKQLEKIVGLQTEAPLKRALIPFGGIKMIE
GSCKAYNRELDPMIKKIFTEYRKTHNQGVFDVYTPDILRCRKSGVLTGLPDAYGRGRIIG
DYRRVALYGIDYLMKDKLAQFTSLQADLENGVNLEQTIRLREEIAEQHRALGQMKEMAAK
YGYDISGPATNAQEAIQWTYFGYLAAVKSQNGAAMSFGRTSTFLDVYIERDLKAGKITEQ
EAQEMVDHLVMKLRMVRFLRTPEYDELFSGDPIWATESIGGMGLDGRTLVTKNSFRFLNT
LYTMGPSPEPNMTILWSEKLPLNFKKFAAKVSIDTSSLQYENDDLMRPDFNNDDYAIACC
VSPMIVGKQMQFFGARANLAKTMLYAINGGVDEKLKMQVGPKSEPIKGDVLNYDEVMERM
DHFMDWLAKQYITALNIIHYMHDKYSYEASLMALHDRDVIRTMACGIAGLSVAADSLSAI
KYAKVKPIRDEDGLAIDFEIEGEYPQFGNNDPRVDDLAVDLVERFMKKIQKLHTYRDAIP
TQSVLTITSNVVYGKKTGNTPDGRRAGAPFGPGANPMHGRDQKGAVASLTSVAKLPFAYA
KDGISYTFSIVPNALGKDDEVRKTNLAGLMDGYFHHEASIEGGQHLNVNVMNREMLLDAM
ENPEKYPQLTIRVSGYAVRFNSLTKEQQQDVITRTFTQSM

# Drug_Target_6_Reaction:
acetyl-CoA + formate = CoA + pyruvate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Acetyl-CoA + formate = CoA + pyruvate

# Drug_Target_6_SwissProt_ID:
P09373

# Drug_Target_6_SwissProt_Name:
PFLB_ECOLI

# Drug_Target_6_Synonyms:
EC 2.3.1.54
Pyruvate formate-lyase 1

# Drug_Target_6_Theoretical_pI:
5.83

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasm

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
BX842578

# Drug_Target_7_GenBank_ID_Protein:
1483534

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
glcB

# Drug_Target_7_Gene_Sequence:
>2226 bp
CTAGCGGGCCGCATCGTCACCGGCCCTGTCCGATGGGGCCGGCTTCTCAGCGGCCCGGGC
CTTAAACTCCCGACGACGTCGGTGCAGGATCGGCTCGGTGTAGCCGTTGGGCTGCTGGGC
CCCGGACAAGATCAGCTCCTGCGCGGCCAGGAAGGCGATACTGTCGTCGAAGTTGGGTGC
CATCGGTCGGTATGCCACGTCGCCCGCGTTTTGTCGATCGACCAACGGCGCCATCCGCTC
CAAGCTGGCCCGCACATCCGCGCTGGTGATCACACCGTGGCGCAGCCAGTTGGCCAACAA
TTGGCTGGAGATTCGCAGCGTGGCCCGGTCCTCCATGAGCGCGACGTCGTGGATGTCGGG
CACCTTCGAGCAGCCGACACCTTGATCAACCCAGCGAACCACGTAGCCGAGGATGGATTG
ACAGTTGTTGTCGACCTCTTCGCGGATCTCGTCGGGAGCCCAGGCCAATTCCTTGGCCAG
CGGAATGGTCAGCAATTGTTCGATGGTGGCGCGACGCTTCCCCGCCAGTCCTTGTTGCAC
CGCGGCGACGTCGACCTGGTGGTAGTGCAGCGCATGCAGGGTGGCCGCAGTGGGAGAGGG
AACCCAGGCGGTGCTGGCCCCGGCGCGCGGCTGGGCGATTTTTGTCTCGACCATGTCGGC
CATCAGCTCGGTCATTGTCCACATGCCCTTGCCGACCTGGGCTCGGCCGCTGAACCCGGC
GGCCAGGCCGGCATCGACGTTGTGGTCCTCGTAGGCCAAGATCCACGGCTGGCTCTTCAT
GGTGCCCTTGCGCACCATCGGGCCGGCCTCCATCGAGGTGTGGATTTCATCGCCGGTGCG
GTCCAGGAACCCGGTGTTGATGAACACCACGCGGTCCGCGGCAGCTTTGATGCACGCCTT
GAGGTTGACCGTGGTCCGGCGTTCCTCGTCCATGATGCCGATCTTCATGGTGTTTTGCGG
CAACCCCAGCACATCTTCAACCCGGCTGAACAGTTCGCAGGTAAACGCCACCTCGGCCGG
ACCGTGCATCTTCGGCTTGACGATGTAGATGGAGCCGGTGCGGCTGTTGATCAGCGGCCC
GTTGACGTCGCTGGCCTTTAGCCCGTGGATGGCGATCAGGCCGGTGAATAGGGCATCCAT
GATGCCTTCGAACACCTCGCTGCCGTCAGTGTCGACGATGGCGTCATTCGTCATCAAGTG
ACCGACGTTGCGGACGAACATGAGGCTGCGTCCAGGCAGCGTGAACTGGCCACCGCCGGG
TGCGGTGTAGTTCCGGTCCCTATTGAGCACCCGCAGGAAAGCGGTGCCGTCCTTGTCTAC
CGCTGCTGCCAGGTCGCCCTTGTTCAGGCCGAGCCAGTTCCGATAACCCAGCACCTTGTC
GGCGGCGTCCACGGCGGCCACCGAGTCCTCGAAGTCCATGATCGTGGTGATCGCGGATTC
CAGGATCACGTCCTTGACGCCGGCCCGGTCGGTGGTGCCGACCTGCGACTCCGGATCGAT
CAGGATCTCGATGTGCAAACCGTGATTGATTAGCAGCACCGATGTCGGCGACTCGGCTGC
GCCGGTGTAGCCGGCGAACTGGCCGGGGTTGGCCAGGCCGGTGGACTTATCCGGCAAGGC
AACCACGAGCTGGCCATCCTGCACTGTGAAACCGGTGGCGTCGCCAAAGGAACCCGACGA
CAGCGGAACACTGTCGTCGAGGAACTTGCGGGCATACGCGATCACCTTGTCGCCACGAAC
CTTGTTGTACGTGGGGCCTTTTTCGGCGCCGTCGGTCTCGGGGATGACATCGGTGCCATA
CAAGGCGTCGTAGAGGGAGCCCCAGCGAGCGTTGGCCGCGTTCAGAGCAAACCGCGCGTT
GAGCACCGGCACCACCAGCTGGGGGCCGGCGGTCGTGGTGATCTCAGCGTCGACACCGGA
CGTGGTGATGGTGAAGTCATCAGGTTCGGGAAGCAGGTAGCCGATCTCGGTGAGGAACTG
GCGGTAGGCATCCATGTCGATGGGCTCGATCACCCGACGCCGGTGCCACTTGTCGATCTG
CGCCTGCAGCTCGTCGCGGGCGTTCAACAGAGCTTGGTTCTGCGGGGTCAGGTCGGCGAC
GACCTTGTCGACGCCCGCCCAGAAGCTGTCCGGGTCGATATCGGTGCCAGGCAGGGCTTC
ATTGTTCACGAAGTCGTAGAGCACCCGAGCGATGCGCAAGTTGCCCACCGACACGCGATC
TGTCAT

# Drug_Target_7_General_Function:
Energy production and conversion

# Drug_Target_7_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
12393860	Smith CV, Huang CC, Miczak A, Russell DG, Sacchettini JC, Honer zu Bentrup K: Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. J Biol Chem. 2003 Jan 17;278(3):1735-43. Epub 2002 Oct 21.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
3190

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
80404

# Drug_Target_7_Name:
Malate synthase G

# Drug_Target_7_Number_of_Residues:
741

# Drug_Target_7_PDB_ID:
1N8W

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF01274	Malate_synthase

# Drug_Target_7_Protein_Sequence:
>Malate synthase G
MTDRVSVGNLRIARVLYDFVNNEALPGTDIDPDSFWAGVDKVVADLTPQNQALLNARDEL
QAQIDKWHRRRVIEPIDMDAYRQFLTEIGYLLPEPDDFTITTSGVDAEITTTAGPQLVVP
VLNARFALNAANARWGSLYDALYGTDVIPETDGAEKGPTYNKVRGDKVIAYARKFLDDSV
PLSSGSFGDATGFTVQDGQLVVALPDKSTGLANPGQFAGYTGAAESPTSVLLINHGLHIE
ILIDPESQVGTTDRAGVKDVILESAITTIMDFEDSVAAVDAADKVLGYRNWLGLNKGDLA
AAVDKDGTAFLRVLNRDRNYTAPGGGQFTLPGRSLMFVRNVGHLMTNDAIVDTDGSEVFE
GIMDALFTGLIAIHGLKASDVNGPLINSRTGSIYIVKPKMHGPAEVAFTCELFSRVEDVL
GLPQNTMKIGIMDEERRTTVNLKACIKAAADRVVFINTGFLDRTGDEIHTSMEAGPMVRK
GTMKSQPWILAYEDHNVDAGLAAGFSGRAQVGKGMWTMTELMADMVETKIAQPRAGASTA
WVPSPTAATLHALHYHQVDVAAVQQGLAGKRRATIEQLLTIPLAKELAWAPDEIREEVDN
NCQSILGYVVRWVDQGVGCSKVPDIHDVALMEDRATLRISSQLLANWLRHGVITSADVRA
SLERMAPLVDRQNAGDVAYRPMAPNFDDSIAFLAAQELILSGAQQPNGYTEPILHRRRRE
FKARAAEKPAPSDRAGDDAAR

# Drug_Target_7_Reaction:
acetyl-CoA + H2O + glyoxylate = (S)-malate + CoA

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Acetyl-CoA + H(2)O + glyoxylate = (S)-malate + CoA

# Drug_Target_7_SwissProt_ID:
P0A5J4

# Drug_Target_7_SwissProt_Name:
MASZ_MYCTU

# Drug_Target_7_Synonyms:
EC 2.3.3.9

# Drug_Target_7_Theoretical_pI:
4.83

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
M24015

# Drug_Target_8_GenBank_ID_Protein:
151259

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
mvaA

# Drug_Target_8_Gene_Sequence:
>1287 bp
ATGAGCCTCGATTCCCGCCTGCCCGCTTTCCGTAACCTGTCCCCTGCCGCGCGCCTGGAC
CACATCGGCCAGTTGCTCGGCCTGAGCCACGACGATGTCAGCCTGCTGGCCAACGCCGGT
GCCCTGCCGATGGACATCGCCAACGGCATGATCGAAAACGTCATCGGCACCTTCGAGCTG
CCCTATGCCGTGGCCAGCAACTTCCAGATCAATGGCCGTGATGTGCTGGTGCCGCTGGTG
GTGGAAGAGCCCTCGATCGTCGCCGCTGCTTCGTACATGGCCAAGCTGGCCCGTGCCAAC
GGCGGCTTCACCACCTCCAGCAGCGCCCCGCTGATGCATGCCCAGGTACAGATCGTCGGC
ATACAGGACCCGCTCAATGCACGCCTGAGCCTGCTGCGCCGCAAAGACGAAATCATTGAA
CTGGCCAACCGCAAGGACCAGTTGCTCAACAGCCTCGGCGGCGGCTGCCGCGACATCGAA
GTGCACACCTTCGCCGATACCCCGCGTGGCCCGATGCTGGTGGCGCACCTGATCGTCGAT
GTACGCGATGCCATGGGCGCCAACACCGTCAATACCATGGCCGAGGCCGTTGCGCCGCTG
ATGGAAGCCATCACCGGGGGCCAGGTACGCCTGCGCATTCTGTCCAACCTGGCCGACCTG
CGCCTGGCCAGGGCCCAGGTGCGGATTACTCCGCAGCAACTGGAAACGGCCGAATTCAGT
GGCGAGGCAGTGATCGAAGGCATCCTCGACGCCTACGCCTTCGCTGCGGTCGACCCTTAC
CGCGCGGCCACCCACAACAAGGGCATCATGAATGGCATCGACCCACTGATCGTCGCCACT
GGCAACGACTGGCGTGCAGTGGAAGCCGGCGCCCATGCGTATGCCTGCCGCAGTGGTCAC
TACGGCTCGCTGACCACCTGGGAAAAGGACAACAACGGCCATTTGGTCGGCACCCTGGAA
ATGCCGATGCCCGTAGGCCTGGTCGGCGGCGCCACCAAAACCCATCCGCTGGCGCAACTG
TCGCTGCGCATCCTCGGCGTGAAAACAGCCCAGGCGCTCGCTGAGATTGCCGTGGCCGTA
GGCCTGGCGCAAAACCTCGGGGCCATGCGCGCCCTGGCCACCGAAGGCATCCAGCGCGGC
CACATGGCCCTGCATGCGCGCAATATTGCCGTGGTGGCGGGCGCCCGAGGCGATGAGGTG
GACTGGGTTGCCCGGCAGTTGGTGGAATACCACGACGTGCGCGCCGACCGCGCCGTAGCA
CTGCTGAAACAAAAGCGCGGCCAATGA

# Drug_Target_8_General_Function:
Lipid transport and metabolism

# Drug_Target_8_General_References:
10377386	Tabernero L, Bochar DA, Rodwell VW, Stauffacher CV: Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7167-71.
1634543	Darnay BG, Wang Y, Rodwell VW: Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1992 Jul 25;267(21):15064-70.
2123872	Wang Y, Darnay BG, Rodwell VW: Identification of the principal catalytically important acidic residue of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem. 1990 Dec 15;265(35):21634-41.
2477360	Wang YL, Beach MJ, Rodwell VW: (S)-3-hydroxy-3-methylglutaryl coenzyme A reductase, a product of the mva operon of Pseudomonas mevalonii, is regulated at the transcriptional level. J Bacteriol. 1989 Oct;171(10):5567-71.
2656635	Beach MJ, Rodwell VW: Cloning, sequencing, and overexpression of mvaA, which encodes Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Bacteriol. 1989 Jun;171(6):2994-3001.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
3387

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
45591

# Drug_Target_8_Name:
3-hydroxy-3-methylglutaryl-coenzyme A reductase

# Drug_Target_8_Number_of_Residues:
428

# Drug_Target_8_PDB_ID:
1T02

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
Not Available

# Drug_Target_8_Protein_Sequence:
>3-hydroxy-3-methylglutaryl-coenzyme A reductase
MSLDSRLPAFRNLSPAARLDHIGQLLGLSHDDVSLLANAGALPMDIANGMIENVIGTFEL
PYAVASNFQINGRDVLVPLVVEEPSIVAAASYMAKLARANGGFTTSSSAPLMHAQVQIVG
IQDPLNARLSLLRRKDEIIELANRKDQLLNSLGGGCRDIEVHTFADTPRGPMLVAHLIVD
VRDAMGANTVNTMAEAVAPLMEAITGGQVRLRILSNLADLRLARAQVRITPQQLETAEFS
GEAVIEGILDAYAFAAVDPYRAATHNKGIMNGIDPLIVATGNDWRAVEAGAHAYACRSGH
YGSLTTWEKDNNGHLVGTLEMPMPVGLVGGATKTHPLAQLSLRILGVKTAQALAEIAVAV
GLAQNLGAMRALATEGIQRGHMALHARNIAVVAGARGDEVDWVARQLVEYHDVRADRAVA
LLKQKRGQ

# Drug_Target_8_Reaction:
(R)-mevalonate + CoA + 2 NAD+ = 3-hydroxy-3-methylglutaryl-CoA + 2 NADH + 2 H+

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
P.mevalonii can use mevalonate as sole carbon source. With this enzyme mevalonate is deacetylated to HMG-CoA

# Drug_Target_8_SwissProt_ID:
P13702

# Drug_Target_8_SwissProt_Name:
MVAA_PSEMV

# Drug_Target_8_Synonyms:
EC 1.1.1.88
HMG-CoA reductase

# Drug_Target_8_Theoretical_pI:
6.71

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasm

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AE005674

# Drug_Target_9_GenBank_ID_Protein:
24054145

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
coaD

# Drug_Target_9_Gene_Sequence:
>480 bp
ATGCAAAAACGGGCGATTTATCCGGGTACTTTCGATCCCATTACCAATGGTCATATCGAT
ATCGTGACGCGCGCCACGCAGATGTTCGATCACGTTATTCTGGCGATTGCCGCCAGCCCC
AGTAAAAAACCGATGTTTACCCTGGAAGAGCGTGTGGCACTGGCACAGCAGGCAACCGCG
CATCTGGGGAACGTGGAAGTGGTCGGGTTTAGTGATTTGATGGCGAACTTCGCCCGTAAT
CAACACGCTACGGTGCTGATTCGTGGCCTGCGTGCGGTGGCGGATTTTGAATATGAAATG
CAGCTGGCGCATATGAATCGCCACTTAATGCCGGAACTGGAAAGTGTGTTTCTGATGCCG
TCGAAAGAGTGGTCGTTTATCTCTTCATCGTTGGTGAAAGAGGTGGCGCGCCATCAGGGC
GATGTCACCCATTTCCTGCCGGAGAATGTCCATCAGGCGCTGATGGCAAAATTAGCGTAG

# Drug_Target_9_General_Function:
Coenzyme transport and metabolism

# Drug_Target_9_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
3199

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
17837

# Drug_Target_9_Name:
Phosphopantetheine adenylyltransferase

# Drug_Target_9_Number_of_Residues:
159

# Drug_Target_9_PDB_ID:
1GN8

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_9_Protein_Sequence:
>Phosphopantetheine adenylyltransferase
MQKRAIYPGTFDPITNGHIDIVTRATQMFDHVILAIAASPSKKPMFTLEERVALAQQATA
HLGNVEVVGFSDLMANFARNQHATVLIRGLRAVADFEYEMQLAHMNRHLMPELESVFLMP
SKEWSFISSSLVKEVARHQGDVTHFLPENVHQALMAKLA

# Drug_Target_9_Reaction:
ATP + pantetheine 4'-phosphate = diphosphate + 3'-dephospho-CoA

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Reversibly transfers an adenylyl group from ATP to 4'- phosphopantetheine, yielding dephospho-CoA (dPCoA) and pyrophosphate

# Drug_Target_9_SwissProt_ID:
P0A6I8

# Drug_Target_9_SwissProt_Name:
COAD_SHIFL

# Drug_Target_9_Synonyms:
Dephospho-CoA pyrophosphorylase
EC 2.7.7.3
PPAT
Pantetheine- phosphate adenylyltransferase

# Drug_Target_9_Theoretical_pI:
7.04

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB01992
